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Abstract 
Pentameric ligand gated ion channels (pLGIC) are key players in the fast signal transduction of 
nerve cells. These ion channels are present in the postsynaptic membrane of the synapses, where 
they convert the chemical signal originating from neurotransmitters, released by presynaptic 
cells, into an electrical response. pLGICs all share a common architecture. They consist of a 
predominantly beta-stranded extracellular domain and an alpha-helical transmembrane pore. 
Both domains comprise of independent folding units, which interact via an extended domain 
interface. Activation within the pentameric ligand-gated ion channel family is initiated by the 
binding of a ligand to a conserved site in the extracellular domain. The following 
conformational rearrangements in this part of the protein are transduced through interactions in 
the interface to the transmembrane part of the protein to activate a selective ion permeation 
pore.  
The dysfunction of this activation process can lead to severe diseases like epilepsy, 
schizophrenia and Alzheimer’s disease. 
Therefore this family has been studied intensively for the last few decades using 
electrophysiology and biochemical techniques, which led to detailed insight into the 
pharmacological behavior of inhibition and modulation, ion selectivity, ligand binding mode 
and gating.  
Only in recent years structural data became available for the family. Initially the structure of 
the acetylcholine binding protein, which resembles the extracellular domain of a functional 
acetylcholine receptor, shed light into the mechanism of agonist and antagonist binding on a 
molecular level. Further on the first high resolution structures of the two cation selective 
prokaryotic homologues (GLIC and ELIC) at two different states were determined. The 
homologue from Erwinia chrysanthemi (ELIC) was solved in a non-conductive state, while the 
protein from Gloeobacter violaceus (GLIC) resembles a potential conductive state. 
 
In the course of my PhD studies I have used a special class of known inhibitors of the cation 
selective nicotinic Acetylcholine Receptor (nAChR) to study their effect on the prokaryotic 
homologue GLIC. This class of inhibitors called “open pore blocker” blocks the channel only 
in its open conformation. They are structurally diverse molecules such as quaternary 
ammonium compounds, local anesthetics and certain transition metal ions and vary 
significantly in their size and hydrophobicity. The only thing they have in common is their 
positive charge. 
Electrophysiological experiments showed that these known inhibitors block the channel GLIC 
in a similar manner as seen for the nAChR. The additional structural studies revealed for the 
first time the molecular basis for this kind inhibition for this class of ion channels. It also 
allowed the discrimination of two distinct sites within the pore region responsible for block. 
The monovalent bulky quaternary ammoniums and local anesthetics bind in the middle of the 
pore and divalent transition metal ions closely interact with a conserved ring of negatively 
charged residues at the intracellular exit of the pore. At the same time the combination of 
structural and electrophysiological data could prove that the crystal structure of GLIC does 
indeed resemble a conductive conformation.  
VI 
 In a different study I had a closer look at the opening mechanism of the prokaryotic homologues 
GLIC and ELIC. Specifically I focused on the gating mechanism, which describes the steps 
between the ligand binding in the extracellular domain and the opening of the ion selective pore 
in the membrane region. Despite the wealth of information based on electrophysiological, 
biochemical and structural data, it was still unclear how the signal is transmitted through the 
protein and which part of the interface is important for this process.  
Based on structural and electrophysiological data of mutants of the domain interface, I could 
show that most mutations in both homologues have the same effect on the gating mechanism, 
which underlines the high conservation of this process. The comparison of this data to literature 
shows that this conservation is not unique for these two homologues, but also can be expanded 
to the cation selective eukaryotic nAChR, where similar mutagenesis studies have been made. 
These findings indicate that both homologues share a very similar gating mechanism, and can 
thus be used as a model system for the entire family. 
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Zusammenfassung 
Pentamere Liganden gesteuerte Ionenkanäle (pLGIC) sind Schlüsselfiguren in der schnellen 
Signalübertragung von Nervenzellen. Diese Ionenkanäle sind in der postsynaptischen Membran 
chemischer Synapsen präsent, wo sie durch Öffnung eines Ionenkanals nach Bindung eines 
Neurotransmitters das chemische Signal der presynaptischen Zelle in ein elektrisches Signal 
umwandeln. Alle pLGICs sing ähnlich aufgebaut. Sie bestehen im Wesentlichen aus einer 
extrazellulären Ligandenbindungsdomäne und einer alpha-helicalen transmembranen Pore. 
Diese beiden Domänen können durch ein ausgedehntes Interface miteinander interagieren. Die 
Aktivierung innerhalb der Familie der pentameren Liganden gesteuerten Kanäle wird durch die 
Bindung eines Liganden in einer konservierten Seite der extrazellulären Domäne ausgelöst. Die 
dadurch entstehende konformationelle Reorganisation in diesem Teil des Proteins wird über 
das Interface zum transmembranen Teil des Proteins weitergeleitet, welches dann eine 
ionenselektive Pore öffnet. 
Eine Fehlfunktion in diesem Aktivierungprozess kann zu schwerwiegenden Krankheiten wie 
Epilepsie, Schizophrenie oder Alzheimer führen. 
Aus diesem Grund wurde diese Familie in den letzten Jahrzehnten sehr intensiv mittels 
Elektrophysiologie und Biochemie erforscht. Diese Untersuchungen führten zu einer 
detaillierten Charakterisierung der Ligandenbindung, des Aktivierungsprozesses, der 
Ionenselektivität sowie der Pharmakologie von Inhibition und Modulation. 
Trotz der Jahrzehnte dauernden Erforschung dieser Proteinfamilie standen strukturelle Daten 
erst in den letzten Jahren zur Verfügung. Zuerst wurde die Struktur des Acetylcholin bindenden 
Proteins publiziert, welches den Mechanismus der Agonisten und Antagonisten Bindung auf 
molekularer Ebene erklärte. Später wurden dann zwei hochaufgelöste Strukturen von zwei 
prokaryotischen Homologen der Familie (GLIC und ELIC) in zwei unterschiedlichen 
Zuständen aufgeklärt. ELIC, der Kanal aus Erwinia chrysanthemi nimmt eine inaktiven 
Konformation ein, während das GLIC, ein Protein aus Gloeobacter violaceus einen möglichen 
aktiven Zustand zeigt.  
 
Während meiner Doktorarbeit habe ich eine spezielle Klasse von bekannten Inhibitoren des 
kationenselektiven nikotinischen Acetylcholin Rezeptors (nAChR) benutzt um ihren Effekt am 
prokaryotischen Homolog GLIC zu testen. Diese Klasse von Inhibitoren nennt sich 
Kanalblocker und blockiert den Kanal nur in seinem offenen Zustand. Die Inhibitoren sind 
strukturell sehr unterschiedlich und umschliessen quaternäre Ammoniumverbindungen, lokale 
Anästhetika und gewisse Übergangsmetalle. Sie unterscheiden sich deutlich in ihrer Grösse und 
ihrer Hydrophobizität. Ihre einzige Gemeinsamkeit ist ihre positive Ladung. 
Elektrophysiologische Experimente zeigten, dass diese bekannten Inhibitoren den Kanal von 
GLIC in einer ähnlichen Art und Weise wie beim nAChR blockieren. Die zusätzlichen 
strukturellen Studien zeigten zum ersten Mal die molekulare Grundlage dieser Art von 
Inhibition für diese Klasse von Ionenkanälen. Es erlaubte ebenfalls die Identifizierung von zwei 
unterschiedlichen Stellen für den Block innerhalb der Porenregion. Die monovalenten, 
sperrigen quaternären Ammonium Verbindungen und die lokalen Anästhetika binden in der 
Mitte der Pore, während die divalenten Übergangsmetalle stark mit einem konservierten Ring 
von negative geladenen Resten am intrazellulären Ende der Pore interagieren. Die Kombination 
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der strukturellen und elektrophysiologischen Daten Unterstützt die Annahme, dass die 
Kristallstruktur von GLIC eine leitende Konformation zeigt. 
 
In einer weiteren Studie befasste ich mich mit der Ligandenaktivierung in den beiden 
porkaryotischen Homologe GLIC und ELIC. Dabei untersuchte ich den ‚Gating‘ Mechanismus, 
welcher die Schritte zwischen der Liganden Bindung in der extrazellulären Domäne und dem 
Öffnen der ionenselektiven Pore in der Membran-Region beschreibt. Trotz der grossen Anzahl 
an Informationen basierend auf elektrophysiologischen, biochemischen und strukturellen 
Daten, war es noch unklar wie dieses Signal innerhalb des Proteins verbreitet wird und welche 
Teile des Interface an diesem Prozess beteiligt sind. 
Basierend auf strukturellen und elektrophysiologischen Daten von Mutanten der 
Interfaceregion, konnte ich zeigen, dass die meisten Mutationen in beiden Homologen die 
gleichen Effekte auf den ‚Gating‘ Mechanismus haben, was auf eine hohe Konservierung dieses 
Prozesses hinweist. Der Vergleich der erhaltenen Daten mit der Literatur zeigte, dass dieser 
Mechanismus nicht nur in diesen beiden Homologen konserviert ist, sondern ähnlich auch im 
ebenfalls kationenselektiven eukaryotischen nAChR, wo ähnliche Mutationen untersucht 
wurden, gilt. Diese Resultate weisen darauf hin, dass die Liganden Aktivierung in der ganzen 
Familie nach ähnlichem Mechanismus erfolgt.  
 
 
   
  
- 1 - 
1 Introduction 
1.1 Nerve cells 
The core of the human nervous system consists of interconnected nerve cells. These 
specialized cells form a complex network throughout our body, which coordinates 
voluntary and involuntary movements and transmits signals between different parts of the 
body. These electrically excitable cells transmit information through chemical and 
electrical signals. Cells at the end of each axon nerve are in contact with neighboring cells 
in structures called synapses. These cells can be muscles or other nerve cells to which 
signals will be transmitted. Two different ways of signal transmission between nerve cells 
are known. In electrical synapses, the two adjacent cells are directly connected over a 
cannel forming gap-junction. Therefore, the electrical signal arriving at the cell end is 
directly transmitted to the adjacent cell, whereas in chemical synapses, no such direct 
junction exists. These cells are separated by an inter-synaptic cleft. This 20 nm wide gap 
cannot be directly crossed by the electrical signal. 
 
 
 
Figure 1: Signal transmission at chemical synapses. The signal is transduced by the following steps. 1) Electrical 
signal in form of a depolarization of the membrane. 2) Influx of calcium ions. 3) Fusion of synaptic vesicles with 
the presynaptic membrane. 4) Diffusion of neurotransmitter to the postsynaptic membrane. 5) Binding of the 
neurotransmitter and opening of an ion channel. 6) Newly generated electrical signal. (Picture taken from (1)). 
The processes at chemical synapses involve several distinct steps (Figure 1). First the action 
potential of the presynaptic cells arrives at the end of the axon, causing a depolarization of 
the membrane. Voltage-activated calcium channels open in response, which, leads to the 
influx of Ca2+ into the cell. The increase in Ca2+ triggers the fusion of neurotransmitter 
containing synaptic vesicles with the presynaptic membrane. Upon fusion of these vesicles 
the neuron transmitters are released into the cleft and can then freely diffuse to the 
postsynaptic membrane. 
On the postsynaptic membrane the neurotransmitters are recognized by specific integral 
membrane proteins (receptors). Upon binding of neurotransmitters these receptors undergo 
a conformational change which leads to an opening of a channel, thus allowing certain ions 
to flow along their electro-chemical gradient into the cell. Depending on the ion selectivity 
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of the channel this influx can lead to an excitatory or inhibitory signal which subsequently 
leads either to stimulation or suppression of electrical activity of the cell (2). 
 
Many of the integral membrane proteins at the postsynaptic cell serving as receptors are 
ligand gated ion channels (LGIC). They are highly regulated by their specific 
neurotransmitter (ligand or agonist). The process of ligand binding and the induced 
conformational change (gating), which lead to the channel opening, is very fast, within the 
millisecond range. This timescale is crucial for fast signaling in the central nervous system 
and at neuromuscular junctions. 
There are three major families of LGICs: the ionotropic glutamate receptors, the nucleotide 
gated ion channels and the pentameric ligand gated ion channels (pLGIC).  
 
1.2 Pentameric Ligand Gated Ion Channels 
The family of pentameric ligand gated ion channels consist of activatory members like 
acetylcholine (nAChR), serotonine (5-HT3R), and inhibitory receptors such as γ - amino-
butyric acid Receptors (GABAAR and GABACR), glycine Receptors (GlyR) and 
invertebrate glutamate-gated chloride channels (GluCl) (3-6).  
The electrical response, is dependent on the selectivity on these channels. The inhibitory 
channels are anion selective, thus their activation leads to a hyperpolarization of the cell, 
which in turn prevents further downstream signaling. The excitatory members, in contrast, 
the cation selective acetylcholine and serotonin receptors are key players in fast electrical 
signal transmission.  
It is therefore not surprising that this protein family is involved in cognitive processes such 
as learning and memory. Since being part in these important processes dysfunction of these 
channels are associated with severe diseases such as epilepsy, Alzheimers disease and 
Schizophrenia (7).  
 
1.3 Activation of pLGICs 
 
Due to the importance and the pharmacological potential of pLGICs (7), they have been 
studied intensively for decades. It has been shown that pLGICs can be activated by a variety 
of chemical compounds, which are called ligands or agonists. Not all of the identified 
agonists play a role in the physiology of pLGICs, but they have served in the 
characterization of these channels, due to differences in the activation and deactivation 
properties. 
Models used to describe the activation and deactivation process of an agonist on a receptor 
have been invented and refined over the years. These models are based on classical enzyme 
kinetics and try to link the experimental observation to the events on the molecular level. 
Initial experiments on pLGIC from Torpedo electroplax and Frog endplates showed that 
agonist binding to the channel does not follow the classical single-site binding mechanism. 
It rather showed a cooperative behavior of the channel exposed to its ligand. Due to this 
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fact it had to be assumed that the protein must contain several allosterically linked binding 
sites.  
Further on Del Castillo and Katz realized that this classical model of cooperation does not 
explain all observed effects. It was seen that different ligands evoke different maximal 
responses on the same channel. Therefore, an even more complex model had to be derived, 
where these partial agonists were taken into account. In this Del Castillo – Katz model two 
states were postulated. Initially both the agonist A and its receptor R are in their free form. 
The first step is only the binding of A to R to from an AR complex. In this step only the 
binding affinity to the site is essential. Only in the second step the activation of the channel 
occurs. The opening of the channel leads to the formation of the AR* state, where the * on 
the AR indicates its activation. In this step a second equilibrium constant describes the 
ability of the bound ligand to trigger the opening of the channel. This property has been 
named efficacy. Using this model they could explain why some agonists, even at full 
occupancy, evoke a smaller response to the channel than others. The lower response could 
be simply explained by a smaller efficacy (8). 
 
Figure 2: A schematic representation of the Del Castillo-Katz model of receptor activation. The vacant receptor 
binds the agonist to form an agonist-bound but inactive complex. This step only depends on the affinity of the 
agonist to the receptor. In the second step, the receptor undergoes a conformational change which leads to the 
active and conductive state. This transition is dependent on the efficacy E, a measure of the ability of the agonist 
to convert the receptor to its active state. (Adapted from (8)). 
In a standard dose-response experiment the response of the channel to the exposure of 
different ligand concentrations is measured. The characteristic quantity obtained from this 
experiment is the EC50, which describes the concentration of the ligand at half maximal 
evoked response. Generally this quantity is called the apparent affinity. The term apparent 
is used since the EC50 takes into account the real affinity and the efficacy of the ligand. The 
relationship between both constants is described in the equation below: 
𝐸𝐶50 =
𝐾D
1 + 𝐸
 
 
Therefore, mutations on the channel characterize by a 2EVC experiments only shows the 
contribution of both the affinity and efficacy (9).  
Yet, this model did not fully explain the experiments on pLGIC. In an additional attempt, 
Monod, Wyman and Changeux (MWC) used the theory of cooperative enzymes. In the 
model, they proposed that the protein could coexist in an open and a closed state in the 
presence and absence of ligands (10). This model, like the Del Castillo – Katz model, takes 
into account a two-step model of agonist binding. But additionally it states that the receptor 
can also open when no ligand is bound and also considers binding of two agonists to the 
channel. 
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Experimentally, it was proven that the channel exists in an open state even in the absence 
of a ligand (11, 12). Despite the fact that population of this state is very low. This model 
not only explains the opening of a free receptor, but also takes into account the possibility 
of several agonists bound to the receptor and therefore describes its cooperative behavior.  
 
 
Figure 3: The schematic representation of the Monod-Wyman-Changeux (MWC) model of allosteric receptor 
activation. In this model, the receptor can adopt both the inactive and the active conformation in the presence or 
absence of agonist. The agonist can stabilize the active conformation and as a result, the efficacies increase from 
the unliganded to the bi-liganded state. This implies that the active conformation has a much higher affinity to the 
agonist than the inactive conformation, which can explain the cooperative behavior in the activation of pLGICs. 
(Adapted from (10)). 
 
1.4 Desensitization 
The prolonged exposure of the channel to its ligand leads to a progressive reduction of the 
response. This phenomenon is called desensitization and is abundant in pLGICs. The 
activation upon application of the agonist is thus only transient. If the agonist is applied for 
longer the response decreases. This reduction is due to the fact that the channel adopts a 
different closed, the desensitized, state. The recovery time from this state is a rather slow 
process and can only happen if the agonist is not present in the solution as the desensitized 
state has a much higher affinity to its ligand than the open or closed state (13-17). To 
explain this phenomenon one has to again take a different model into account. In this 
circular model the receptor can adopt three states: Resting (AR), Active (AR*) and 
Desensitized (D) (Figure 4). In contrast to the transition from AR to AR*, which requires 
high ligand concentrations, the transition from AR to D can occur already at much lower 
concentrations. Consequently D must have a much higher affinity (13).  
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Figure 4: Schematic representation of the circular desensitization model. The first two steps (bottom) are identical 
to the Del Castillo-Katz model of receptor activation. The additional desensitized state (top) can either directly 
change into the ligand bound resting state or the activated open state (although with different rate constants). 
 
Desensitization is a classical property of allosteric proteins. Experimental models showed 
that for allosteric proteins all states are populated at any time with different probabilities. 
Quantifications on nAChR for example showed that up to 1 % of the receptor is present in 
D in the absence of any ligand (16). Due to the high affinity of the D state to the agonist, 
the receptors can be quantitatively desensitized even by concentrations of agonist too low 
to activate the receptor. On the other hand, the estimated rate of dissociation of the agonist 
from the desensitized state is much faster than the rate of recovery and it is therefore 
assumed that the recovery from desensitization is independent of the agonist affinity (14). 
Desensitization is an intrinsic feature of almost all pLGICs. However, its physiological 
function is still ambiguous. In synapses, neurotransmitters are instantly reabsorbed or 
degraded and only present for several milliseconds, but the desensitization rates of most 
pLGICs are on the second time scale and thus much slower. Desensitization nevertheless 
could still accumulate during repetitive excitations of a synapse. The most common 
explanations are that desensitization is either a mechanism for the protection of the cells 
against excitotoxicity (15) or a mechanism to shape the short term plasticity of synapses 
(18). 
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1.5 Modulation of pLGICs 
As pLGICs play an important role in the central nervous system, it is not surprising that 
they are also influenced by a variety of natural and artificial compounds. These modulating 
drugs either enhance or inhibit the receptor response in a process called positive or negative 
modulation. The way these modulators can interact with the receptor are diverse, 
nevertheless they can be grouped based on their interaction with the channel. (1) Open pore 
blockers are interacting with the pore region in the activated channel, (2) orthosteric ligands 
bind to the same location as the agonist and (3) modulators where the binding site and the 
effectory site are different from one another. The off-site modulators (3) will be discussed 
in detail in the appendix (8.1.1.2) 
1.5.1 Open pore block 
The inhibition of ion flow by the obstruction of the channel is called open pore block. 
Certain chemical compounds, frequently carrying a net charge corresponding to the ion 
selectivity of the channel, are attracted to the open pore, but are too big to pass the channel, 
which leads to a blockage of the ion flow (19).Electrophysiological and crosslinking 
experiments shed light in to the mechanism of open pore block (20-22). It was shown that 
open pore blocker bind in an uncooperative, voltage dependent way. The voltage 
dependence shows that these compounds have to pass part of the membrane potential to 
reach their binding site, which implies that the actual event of blockage has to be within the 
membrane. Additionally, many blockers can only block the channel from one side. Due to 
the fact that open channel blockers can only bind to the channel in a conductive 
conformation their binding leads to a stabilization of the open conformation and the channel 
can only close once the inhibitor diffuses off (23-25). This phenomenon has been described 
by Armstrong as the ‘‘foot-in-the-door’’ (26, 27). 
 
 
Figure 5: A schematic representation of the mode of of action of open channel blockers. Until the last step this 
model represents a simplified version of the Monod-Wyman-Changeux (MWC) model of activation. Therefore 
once the channel is activated (AR2*) it can become blocked (i.e. by QX, a quaternary lidocaine derivative) and the 
binding of the drug then prevents the channel from closing (Adapted from (19)). 
 
To measure the potency of inhibition of an open pore blocker a dose response experiment 
is performed. In this experiment the responses of the channel at a specific agonist 
concentration for different pore blocker concentrations are measured. These responses 
normalized to the current in the absence of inhibition are then plotted against the 
concentration of the inhibitor. The concentration which leads to half maximal inhibition is 
termed IC50. The IC50 is also called apparent affinity (similar to the EC50) and can be used 
to compare the potencies of pore blockers at a certain membrane potential (28). It is 
apparent that the binding is strongly influenced by the membrane potential. 
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Figure 6: (left) Example of a dose response experiment at a specific holding potential (-80mV) for an open pore 
blocker. The response of the channel at a certain agonist concentration is measured at different open pore blocker 
concentrations and then fitted by a single-site binding isotherm. The concentration which leads to half maximal 
response is termed IC50 (apparent binding affinity) and can be used to compare the potency of different pore 
blockers at a certain holding potential. (right) The same dose response experiment as on the left at different holding 
potentials. Starting from a holding potential of -40mV (light green) to -120mV (violet). It clearly shows that the 
apparent affinity is higher at higher holding potentials. 
For the cation-selective members of the pLGIC family structurally diverse molecules (i.e. 
quaternary ammoniums, local anesthetics and certain transition metal ions (21, 29-32) have 
been found to exhibit such a behavior. The only common property is their positive charge, 
whereas they vary significantly in their size and hydrophobicity. These open pore blockers 
can be subdivided into two different classes: (1) the large and bulky monovalent and (2) 
the divalent transition metal ions. 
 
While the first group (1) is site specific and can only block the channel from the 
extracellular side, for the second group (2) this is not the case. Divalent ions have been 
shown to directly interact with a conserved stretch of negatively charge residues at the pore 
end from both sides of the membrane (33). Thus these ions can modulate the channel from 
the intra- and extracellular side. 
This tight interaction has already been proposed in the absence of structural data, since it 
has been observed that small divalent ions pass the pore, whereas larger transition metal 
ions lead to either a reduction or a complete disappearance of the currents. The reduction 
of the flow arises from a tighter interaction of divalent ions with the pore lining which in 
turn becomes rate limiting for ion flow. This feature indicates a close relationship between 
permeation and blockage for these divalent ions (34-36). Despite the wealth of information 
about open pore block the structural basis of this mechanism is still unclear. 
 
1.5.2 Competitive inhibition 
In contrast to the open pore blockers, which bind in the pore region, competitive inhibitors 
bind in the extracellular domain. They belong to the second group – the orthsteric ligands 
and compete with the actual ligand for the same binding site, but contrary to the ligand, 
they do not trigger any response upon binding. By exposing the receptor to a higher 
concentration of ligand the effect of the competitive inhibitor can be removed. Inhibition 
thus only depends on the binding affinities and concentration differences between the 
ligand and its competitor. Therefore, the inhibitor leads to a shift of the dose repose curve 
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to higher ligand concentration, but is not changing the shape or the maximal response of 
the curve (Figure 7). Competitive inhibitors are known for all member of the pLGIC family. 
They can be, either similar to their agonists or protein based as found for certain snake 
toxins. Well-known small molecule antagonists are DhβE and d-tubocuracine for nAChR, 
strychinnie for GlyRs, biculline for GABARs and morphine and methadone for the 
5HT3Rs. 
 
To determine the affinity of a competitive inhibitor, the agonist displacement in a dose 
response experiment can be quantified by a Schild plot (37, 38). 
 
log(𝐷𝑅 − 1) = log[𝐵] − 𝑝𝐴2 
DR is the dose ratio, meaning the ratio of equiactive agonist concentrations in the absence 
and presence of inhibitor (e.g.
𝐸𝐶50′
𝐸𝐶50
), [B] is the concentration of the inhibitor and pA2 
corresponds to the logarithm of the dissociation constant KB of the inhibitor. A plot of [B] 
against (DR-1) in a double logarithmic graph gives a linear relationship with a slope of 
unity and the intercept pA2 which is the logarithm of the inhibitor concentration that is 
required to double the equiactive concentration of the agonist. This value corresponds to 
the dissociation constant of the inhibitor. 
 
 
Figure 7: (a) Dose response curves of a receptor activated by its agonist at different concentrations of a competitive 
inhibitor. Due to the presence of the inhibitor, the curves shift to higher agonist concentrations. The data is 
transformed to the dose ratio at the corresponding antagonist concentrations and plotted in a Schild plot (b). The 
dissociation constant of the inhibitor can be deduced from the X-axis intercept. (Picture taken and text adapted 
from (18)). 
 
1.6 Prokaryotic homologues 
Initially all functional data on pLGICs was obtained from eukaryotic family members as 
prokaryotic members have not yet been identified.  
With the abundance of genomic data, more and more prokaryotic species and their genes 
could be analyzed. These advances have led in 2005 to the first identification of prokaryotic 
homologues by Tasneem and coworkers (39). Despite the very low sequence identity, 
which is below 30%, the key residues of the family are conserved. This was in a way 
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surprising, since it was thought that pLGICs were only abundant in the tree of higher 
organisms, which have a central nerve system.  
The first characterization of such a prokaryotic pLGIC (GLIC) from the bacterium 
Gloeobacter violaceus was published in 2007 by Boquet and colleagues (40). They 
identified GLIC as a homopentameric pH gated cation selective channel and confirmed the 
pentameric structure by electron microscopy and unspecific crosslinking. 
 
1.7 Structural information 
Whereas the organization of pLGICs was revealed from electron microscopy high 
resolution structures of pLGICs became available only recently. This started in 2001 when 
Brejc and colleagues (41) determined the structure of the acetylcholine binding protein 
(AChBP) of the mollusk Lymnaea stagnalis. Sequence alignment underlines its 
conservation to the extra cellular domain of the nAChR. This high resolution (2.7 Å) X-
Ray structure gave detailed insight into the ligand binding pocket and it revealed the 
relation between key residues for the interaction with ligands and competitive inhibitors. 
It took some time until the first full length pLGIC became available at high resolution. The 
first EM structures on the nicotinic receptor from the electric organ of torpedo (42-44) shed 
light into the architecture of the protein. Despite the comparably low resolution, this pioneer 
work significantly contributed to understanding of ion selectivity and the gating mechanism 
(45-47). 
Due to bottlenecks in the production of eukaryotic membrane proteins and since the 
receptors purified from its natural source did not allow the growth of diffracting crystals, 
structural studies of this family initially failed. However, with the identification of 
prokaryotic homologues has allowed to overcome this bottleneck (48). Thus only few years 
after prokaryotic homologues were identified, the first high resolution structures of such 
proteins were determined (33, 49, 50). These high resolution structures allowed detailed 
interpretations of functional properties of the channels. The first X-Ray structures for cation 
selective pLGICs came from two prokaryotic organisms. The first structure was from 
Eriwinia chrysanthemi (ELIC). This ligand activated channel was crystallized in the 
absence of its ligand in a non – conductive state. The second structure from Gloeobactoer 
violaceus, a pH activated channel, was solved in a potential open, conductive, 
conformation. 
Only in 2011 did the first eukaryotic member of the family become available. The protein 
from Caenirhabditis elegans was the first anion selective member of the family. It shed 
light on anion selectivity, ligand binding and allosteric modulation (6). 
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Figure 8: Top and side view of the available structures of pLGICs. The membrane is indicated as grey bars. A 
comparison of the cartoon representations of the secondary structure elements reveals the strong structural 
conservation within the family. Each of the five protomers is formed by an extracellular domain which consists of 
two β-sheets and a transmembrane domain of four α-helices. The residues of the second transmembrane helix line 
the pore which spans the membrane along the symmetry axis of the pentamer. (Picture and text taken from (18)) 
Despite the very low sequence identity between homologues, their structural conservation 
is striking (Figure 8). Whether pLGICs are inhibitory or excitatory, they all share the same 
overall architecture. The Receptor is formed by five subunits, which are either identical or 
very homologous. Each subunit consists of an extracellular cellular and a membrane 
spanning domain. The extracellular ligand binding domain is an open water-filled chamber 
that provides access to the channel forming pore of the transmembrane domain. 
 
1.7.1 The extracellular domain 
The extracellular domain resembles a cylindrical tube. Its height is 60 Å and its diameter is 
80 Å. The open aqueous chamber in the middle of the pentamer is 20 Å wide (Figure 9). 
The extracellular part of the protein resembles a turbine, with five blades along its 
symmetry axis. Each subunit is enclosed by two neighbors, with a buried surface of around 
2500 Å2. A subunit consists of 10 β - strands forming a β - sandwich of two sheets with an 
immonuglobin like fold.  
The ligand binding site is formed at the subunit interface as shown in Figure 9. 
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Figure 9: The structure of the acetylcholine binding protein of T. Californica representing the extracellular domain 
of the nAChR with the typical pentameric assembly of the pLGIC family. (left) The side view shows the ligand 
binding site, indicated by the bound agonist carbachol. It is located in the large interface between the principal 
(blue) and the complementary (red) subunit. (right) The top view along the fivefold axis depicts the windmill-like 
structure of the pentamer formed by five subunits, which resembles a turbine. It encloses a large vestibule in the 
center of the pentamer, which gives access to the pore in the full receptor. (Picture taken from (18)). 
 
1.7.2 The pore 
Adjacent to the extracellular domain is the membrane spanning pore domain. Only the first 
full-length structures (6, 33, 42, 44, 49, 50) did show a clear picture of how the pore is 
constructed. 
The four helical segments per subunit are arranged around a five-fold axis of symmetry, 
forming an inner ring of α helices (α2), which line the pore, and an outer shell of α helices 
(α1, α3 and α4), which surround the inner ring and shield it from lipids (Figure 10). 
 
 
Figure 10: The structure of the transmembrane region of ELIC (ribbon representation) illustrates the typical 
pentameric assembly of the pLGIC family. (left) The top view shows the pore formed by the α2 of each subunit. 
(right) side view perpendicular to the pore axis. One subunit has been removed for clarity. This view as well shows 
that the pore is formed by the membrane spanning α2. α1 and α3 are at the subunit interface while α4 is loosely 
attached. 
The pore facing residues form a distinct pattern of residues with physico-chemical 
properties that are conserved for the cation selective members of the family (top Figure 11). 
It is lined by three consecutive rings of hydrophobic residues, followed by two rings of 
polar residues and a negatively charged ring. 
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The first high resolution structure (ELIC) was crystallized in the absence of its agonist in a 
non-conductive conformation. There, the α2 helices are arranged almost parallel to each 
other in the membrane. In ELIC the first pore lining amino acid at the constriction is a ring 
of phenylalanines. This aromatic residue occludes the pore (51). The phenylalanine ring is 
followed by two additional rings of hydrophobic residues, none of which is water 
accessible. In the other prokaryotic homologue, GLIC, the pore shows a potential open 
conformation. There the α2 helices are bent in a slight angle with regard to one another, 
thus forming a funnel shaped, water accessible, pore. In this structure the hydrophobic 
residues of the first ring have moved apart and are no longer occluding the pore. At the 
intracellular end of the α2 helix, the negatively charged residues have moved closer to from 
a selectivity filter (Figure 11). 
 
Figure 11: (top) Sequence alignment of the pore forming α2 helix of GLIC, ELIC and nAChR. The pore lining 
residues are conserved and form six rings with distinct chemical properties. The three hydrophobic rings on the 
extracellular side constitute the gate, whereas the inner two polar and the intracellular charged ring form a 
selectivity filter. (bottom) Comparison of the pore structures of ELIC and GLIC showing two conformational 
states. ELIC is in a non-conductive state, in which the hydrophobic rings obstruct the pore. The GLIC pore is in 
the open conformation, where the hydrophobic rings separated from each other to open the gate whereas the polar 
and charged rings contracted to form a selectivity filter (Adapted from (52)).  
 
Due to the high degree of structural conservation between known structures (prokaryotic 
and eukaryotic) (53), it is quite likely that the underlying mechanism for gating is conserved 
(5). This emphasizes the potential of the prokaryotic homologues to serve as a model for 
the complex and diverse family. 
 
1.7.3 Ion selectivity 
The structures of pLGICs have provided structural insight into the ion selectivity of the 
family. 
The main determinants of ion selectivity in an ion channel are frequently found at the 
narrowest part of the channel. This constriction can limit the size of the ions which can still 
permeate the channel (see also “Open pore block” 1.5.1), whereas the pore lining residues 
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and their chemical interaction to the solvent can discriminate different ions and influence 
the solvent permeation (53). The hydrophilic or charged amino acids in the pore reduce the 
energetic barrier of the hydrophobic membrane and thus allow ion flux through the channel 
across the membrane (54). The combination of the steric features and the polar and charged 
residues make an ion channel capable to discriminate between different ions. 
In pLGICs the pore region is not the only site for the ion selectivity. The vestibule of 
extracellular domain is as well narrow enough (∼20 Å wide) to ensure that charged groups 
lining their surfaces would interact electrostatically with the permeating ions. Nevertheless 
these vestibules are wide enough not to directly interact, which could slow the movement 
of the ions, as it has seen in the pore region for certain divalent ions (55, 56).  
At a closer look on the surface potential of the known cation selective channels, it is 
apparent that the extracellular and the intracellular vestibules are almost entirely negatively 
charged (Figure 12). The resulting cation-stabilizing environment would increase the 
concentration of cations relative to that of anions at both entrances of the narrow membrane 
pore, and in that way promote bidirectional transport of cations through the open channel. 
It is therefore likely that the vestibules contribute significantly to the charge selectivity of 
the channel, and that the “selectivity filter” at the end of the pore is not the only region for 
ion selectivity (57).  
 
The pLGIC are not selective for a certain kind of ion. Their selectivity is mainly based on 
the charge of the ion. Therefore barely any discrimination exists between different 
monovalent ions and even divalent ions and bigger organic cations were shown to permeate 
certain channels. A similar behavior has been also seen for the anion selective part of the 
family. Due to this rather poor selectivity, these channels are termed charge selective. 
 
 
Figure 12: The calculated surface potential of the cation selective GLIC is shown (negative potential red and 
positive potential blue). The figure highlights the role of the electrostatic potential on the underlying mechanism 
of the charge selectivity of pLGICs. They create an attractive environment for the conducted ions and an 
insurmountable barrier for their counter ions. (Picture and text adapted and taken from (18)). 
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1.8 Ligand recognition and conformational changes in the extracellular 
domain 
 
To form an ion selective pore the channel first needs to be activated by its ligand. For cation 
selective pLGICs, the mode of ligand binding to the ligand binding pocket is very similar 
(58). The pocket is located in the extracellular domain at the interface between two adjacent 
subunits, called the principal and complementary site (Figure 9). 
The ligand binding domain itself can exist in various conformations with different affinities 
for the ligand. As previously discussed in the so called resting sate, the affinity to the ligand 
is low. However after the opening of the channel, which induces underlying conformational 
changes, the ligand binding affinity increases. After a longer exposer of the ligand to the 
channel enters the desensitized state. In this state, the ligand has an up to 1000 fold higher 
affinity than in the open state. These different affinities indicate the existence of at least 
three different states with potentially unique conformations of the ligand binding domain.  
The induced conformational changes upon ligand binding were extensively investigated 
using the AChBP. The protein was crystallized with several agonists and antagonists (59). 
The biggest structural changes in the structure were seen in the C loop. The tip of this loop 
does in the apo state only loosely interact with the rest of the protein. Upon binding of the 
ligand this loop closes the ligand binding pocket (Figure 13). This closing is called the C – 
loop capping. In contrast to the agonist the binding of the antagonist leads to a further 
opening of the C – loop (red conformation in Figure 13).  
 
 
Figure 13: Mechanism of C-loop capping derived from structures of the AChBP, crystallized in the apo-, agonist- 
and antagonist bound state. The C-loop experiences a contraction from the apo structure (in green) to the agonist 
bound structure (in blue). This conformational change is believed to be the first step in the activation process of 
pLGICs. Antagonists on the other hand were found to push the C-loop outwards, corresponding to the observed 
difference between the apo structure (in green) and the antagonist bound structure (in red). Competitive inhibitors 
are therefore believed to inhibit receptor activation by preventing the C-loop capping. (Adapted from (59)) 
 
The use of the AChBP to serve as a model for the activation of the receptor is limited since 
ligand binding is not cooperative as it is for pLGICs. Nevertheless a functional chimera of 
the AChBP with the 5HT3 receptors transmembrane part could be produced (60). This 
chimera shows that the AChBP can serve as functional part of a full length receptor. 
Remarkably as part of a full receptor it also shows the observed cooperative behavior of 
the family. 
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With the structures of the first full-length receptors in two different states (a conductive in 
GLIC and a non-conductive in ELIC), it was shown that the C – capping was conserved in 
these cases (5, 33, 49, 50). The structures also indicated potential changes in the 
extracellular domain upon ligand binding. Differences were observed in the F – loop and 
in the β1 – β2 turn at the interface of the extracellular domain to the pore domain. The best 
way to describe the differences in the extracellular domian between GLIC and ELIC is a 
12º rotation around an axis parallel to the two β sheets of the extra cellular domain (Figure 
14). 
 
Figure 14: Conformational differences between the structures of ELIC and GLIC. The extracellular domain is 
rotated along an axis between the β-sheets (adapted from (5)). 
 
1.9 From binding to opening - Gating 
 
Despite the insight gained form the structures of AChBP one very important question still 
remained unclear: How are the ligand binding and the pore opening connected? These two 
events must be directly linked despite the several nanometer distances between the 
locations.  
The AChBP shows no structural differences upon ligand binding in the area, which would 
form the interface to the pore domain in intact receptors. An interesting feature of the 
extracellular domain in the known chimeras is that these won’t work unless the extracellular 
loop β1 – β2 is exchanged with the corresponding loop of the homologue which forms the 
pore domain (60, 61). This indicates, that this specific loop interaction between the α2 – α3 
pore loop to the β1 – β2 turn is crucial for pore opening. 
The full length receptor structures offered insight into the potential structural 
rearrangements during activation, since they show two different states, a conductive 
channel for GLIC and a non-conductive channel for ELIC. The most obvious change at the 
interface of the pore and the extracellular domain are observed in the β1 – β2 turn of the 
extracellular domain and the α2 - α3 loop of the pore. In GLIC, these two loops are in direct 
contact with one another. A lysine at the tip of the β1 – β2 turn interacts directly with a 
conserved proline of the α2 – α3 loop. In ELIC these residues are approximately 7 Å apart 
from each other (Figure 15, left). This β1 – β2 turn in GLIC is stabilized by a conserved 
bridge salt-bridge (Figure 15, right middle). In ELIC this salt-bridge is absent and the 
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conserved negatively charged residue, which forms this interaction in GLIC, is a polar 
threonine. This disruption of the salt bridge might be the cause of this big difference of the 
loop position. The importance of this conserved salt bridge for gating has previously been 
described as part of the ‘principal pathway of gating’ by Sine and colleagues (45). In the 
nAChR and in GLIC this salt bridge is formed by a conserved aspartate residue of the cys–
loop and an equally conserved arginine of the β10 - α1 linker. 
 
 
Figure 15: Differences between the ELIC and the GLIC structures in the coupling interface of the extracellular 
and the transmembrane domain. The interaction of the residue at the tip of the β1 - β2 turn with the α2 - α3 loop 
is believed to couple the movement of the domains. The schematic representation depicts the interactions in the 
principal pathway of coupling where the signal of agonist binding is transmitted to the α2 - α3 loop via the β1 - β2 
turn which is additionally stabilized by a hydrogen bond to the pre α1 region. (adapted from (5)) 
The comparison of the ELIC and GLIC structures shows that the conformation of the cys-
loop in both prokaryotic homologues is similar. Therefore the importance of this highly 
conserved motif and its role in the gating cycle remains unclear (5). Remarkably, mutations 
within this loop in other receptors have shown a significant alteration in the activation 
pattern thus underlining its involvement in gating (46). One residue of the cys-loop, which 
is slightly above the interface of the pore and the extracellular domain, is part in the 
previously mentioned conserved salt bridge of the ‘principal pathway of gating’ (45). This 
indicated that at least the location of the cys-loop must be important for activation. In 
further studies it has then been proposed that this pathway contributes jointly together with 
another pathway, the ‘cys-loop pathway’ in the transducing of agonist binding to the gating 
of the nAChR channels (46). The ‘cys-loop pathway’ contains residues, which form a 
hydrophobic core between the cys-loop, the β10 - α1 linker and the α2 – α3 loop (Figure 
16). Mutations of these residues show significant reduced channel activity (46). 
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Figure 16: Cryo-electron microscopic structure of the Torpedo nAChR (PDB code 2bg9). [left] The pentameric 
nAChR in the membrane (parallel black lines) is shown with one of the α-subunits highlighted; β-strands are 
orange and α-helices red. β-Strand 10 preceding transmembrane domain α1 region is green. The boxed region is 
the junction of extracellular and pore domains, shown at higher magnification on the right. [right] Residues from 
three converging regions of the α-subunit (Cys-loop, β10-α1 linker, α2–α3 loop) which are important in the ‘cys-
loop pathway’ are shown in stick representation overlaid with colored van der Waals surfaces. (Taken from (46)) 
The full length receptor structures also offered insight into the potential structural 
rearrangements of the pore domain. In ELIC this pore is occluded and not permeable to 
ions, while in GLIC the pore shows a funnel shaped water accessible cavity (Figure 11 and 
Figure 17, left) that would allow ions to flow through the membrane. The biggest 
differences in this region between these two structures (Figure 17, left) are found in the 
helices α2 and α3. Based on these structural differences a rotation of the α2 and α3 helices 
of around 12º along an axis in the pore region perpendicular to the pore axis was proposed 
as potential mechanism for pore opening. This movement would separate the three 
hydrophobic rings, which occlude the pore in the non – conductive state. While at the 
intracellular region of the pore the polar and charged rings are getting closer, thus allowing 
the formation of a polar constriction, that allows desolvated ions to permeate the pore (5). 
In contrast to this model crosslinking experiments in GLIC show a different conformational 
change in the pore domain as potential mechanism for channel closing (Figure 17, right). 
In these experiments a local unwinding on the extracellular end of the pore forming helix 
α2 was observed while helix α3 remained unchanged (Figure 17, right (62)). In this model 
the polar constriction and the ‘selectivity filter’ have similar conformations also in the 
closed conformation thus suggesting that the structure of ELIC does neither describe a 
resting nor an activated conformation. 
 
 
Figure 17: Comparison of the two proposed mechanism of pore opening. On the left is the mechanism based on 
the two different prokaryotic structures ELIC and GLIC. The helix α2 and α3 undergo a combined rotation 
around an axis perpendicular of the pore axis. On the right is the mechanism based on crosslinking experiments. 
In this mechanism does the α2 helix collapse and thus occlude the pore, while the α3 remains unchanged (Adapted 
from (5, 62, 63)). 
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Although there are several potential scenarios for the processes underlying ligand binding 
to the pore opening, in all cases the interface region between the extracellular and the 
transmembrane must couple these different events. In summary, studies have identified 
interactions of the β1 – β2 turn and the cys-loop to the α2 – α3 loop, the linker of the β10 - 
α1 as the main element for the coupling (45, 64, 65). The location of the residues between 
the extracellular and pore domains and their sequence conservation suggest that they form 
a functionally coupled network that contributes to the rapid and efficient channel gating 
characteristic of the nAChR (46, 66). Despite the wealth of functional data and due to the 
problem of assigning the available structures to a state within the activation cycle it was 
still unclear which network of interactions lead to the activation of the channel. Therefore 
questions concerning the gating mechanism still remain to be answered. 
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1.10 Aim of Thesis 
Detailed models for pLGICs function were developed over the last few decades. In 
combination with the recent high-resolution structures of the prokaryotic homologues ELIC 
and GLIC and the eukaryotic protein GluCl these studies have led to a deeper understanding 
of structure-function relationships. However, despite all efforts of combining structural and 
functional data, the detailed mechanistic understanding of channel activation is still not 
fully understood. Currently all available structures and model systems to study the 
mechanism of gating have their drawbacks. Firstly, there is currently no model protein 
whose structure has been determined at high resolution in more than one state. Therefore 
the different states seen in the structures could arise from distinct properties of each 
particular channel. 
The homologue GLIC is not activated by a ligand, but by the protonation state of the 
channel itself. Such mechanism has never been seen in any other family member. GluCl, 
on the other hand, is a truncated version of a homopentamer that is only partially activated 
by the addition of its ligand. For full activation ivermectin, an allosteric enhancer molecule, 
has to be added. Such a behavior is not seen in the naturally abundant GluCl channels. 
Therefore, the use of GluCl as a model system for functional studies is limited. In contrast, 
ELIC has promising properties required for a model system. It is activated by a variety of 
small molecules and is desensitized by prolonged application of its ligand. The major 
drawback of this model, however, is the fact that the structure shows an inactive, non-
conductive conformation, which so far could not be assigned to a specific state in the 
activation cycle and despite different approaches, no other conformation could be 
determined. 
 
The first aim of this thesis was to investigate whether known open pore blockers of cation 
selective nAChRs act in a similar way on the prokaryotic homologue GLIC. As part of the 
study I wanted to use the potential conductive state of the crystal structure of GLIC to 
visualize this pore block for the first time in the family. The combination of 
electrophysiological and structural data should also confirm that the GLIC structure is 
indeed an open, conductive, conformation of the channel.  
In a second study, I aimed to investigate which residues of the interface between the 
extracellular and the pore domain are important in the gating mechanism of the two 
prokaryotic homologues ELIC and GLIC and then relate these findings with the published 
data available for the family to gain a deeper understanding of the activation mechanism. 
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2 Results 
2.1 Pore Block 
The pharmacology of pLGICs has been characterized for decades with a variety of chemical 
compounds. A well-studied group of compounds are ‘open channel blockers’. The charged 
pore blockers are attracted into the channel region by their positive net charge. However, 
due to their bulky size, they cannot pass the pore and therefore block the open channel. This 
leads to a reduction or elimination of the overall measured current flow since some or all 
pores are occluded and ions cannot pass the membrane along their electrochemical gradient. 
Open pore blockers are pharmacologically interesting and were also used to gain 
information about pLGICs. In a combination of electrophysiological recording and the use 
of the substituted cysteine accessibility (SCAM) method the general mechanism of open 
channel block could be studied for the nAChR. With the first high-resolution structure of 
a, potential, conductive state structural studies of complexes with these modulating 
compounds came within reach. The prokaryotic homologue GLIC was identified as a pH 
activated member of the pLGIC family. Its crystal structure showed a potential conductive 
conformation, which made it a perfect system to study channel blockers for the first time 
on a structural level and by electrophysiology and thus gain insight to which degree the 
conductive state seen in the structure agrees with the experiments found in the lipid 
environment. The following publication describes the work on open channel block in GLIC 
that reveals for the first time the detailed structural basis of this mechanism for the family. 
 
 
Figure 18: Open channel block. 2EVC recording of a GLIC-RNA injected Xenopus Laevis oocyte at a holding 
potential of -50mV. The figure shows the opening of GLIC at pH 4 followed by its reversible inhibition by 10 mM 
TBA+ (tetrabutylammonium). 
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2.2 Signal transduction at the domain interface of pentameric ligand-
gated ion channels 
Before a pLGIC can be blocked with open pore blockers, the channel first needs to be 
activated. The activation within the pLGIC family is initiated by the binding of a ligand to 
a conserved site in the extracellular domain. The following conformational rearrangements 
in this part of the protein are transduced through interactions in the interface to the 
transmembrane part of the protein to activate a selective ion permeable pore. Several studies 
have focused on this activation process. A study where a functional chimera of the 
prokaryotic extracellular domain of GLIC and the eukaryotic pore domain of GlyR were 
constructed showed that this chimera was only functional if the β1 - β2 turn of the pore 
domain and the α2 - α3 loops of the extracellular domain were from the same homologue 
(61). This study indicated that these two loops form an interaction network which is 
important for channel activation. Further studies have led to the identification of several 
key residues in the interface region of the nAChR, which were proposed to be part of the 
‘principal pathway of gating’ (45) and the ‘cys-loop’ pathway (46). The residues of these 
pathways are highly conserved within the family and are located on four loops in close 
vicinity of the interface between the extracellular- and the pore domain. The loops 
harboring these residues include the β1 - β2, the cys-, the β8 - β9, the β10 - α1 and the α2 - 
α3 loop (46). 
With the appearance of high resolution structures (6, 33, 49, 50) from family members of 
the pLGIC, insights into the structural relationship between conserved residues could be 
obtained. But due to the ambiguity to assign the structures to a specific state within the 
activation process and the complexity of structure function relationships, the detailed 
mechanisms of gating remained unclear. 
 
 
Figure 19: Side view of the pLGIC ELIC. Highlighted in red is the ligand binding domain and in orange the pore 
domain. It is apparent that ligand binding must induce a structural rearrangement over a large distance to trigger 
the opening of the pore. 
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In this study, I aimed to characterize the interactions at the domain interface responsible 
for the transduction of conformational changes between both folded entities of the 
prokaryotic homologues ELIC and GLIC. My study has revealed a conserved cluster of 
residues, which play a key role in the transduction of signals and is in overall agreement 
with the published data on the prokaryotic and eukaryotic homologues. 
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2.2.1 Alanine scanning mutagenesis of the domain interface  
To investigate the role of interactions in the interface between the extracellular and the 
transmembrane domain of pentameric ligand gated ion channels, I have mutated residues 
that make contacts between these domains and certain residues that are in close proximity 
to the interface in ELIC and GLIC to alanine. My mutagenesis study has also included 
conserved residues forming a branched salt bridge in GLIC, which are only partly present 
in ELIC. This salt bridge was previously identified to display a strong effect on gating in 
the nAChR and was thus assigned to contribute to the ‘principle pathway of gating’ (45). 
The interacting regions were grouped, according to their location in the protein (i.e. β1 - β2 
turn, β6 - β7 loop (cys-loop), β8 - β9 loop, α2 - α3 loop and the residues of the β10 - α1 
linker region, Figure 20). 
 
 
Figure 20: [left] Ribbon representation of GLIC (PDB code 3EHZ). The extracellular domain is colored in blue, 
the pore domain in green and the residues at the domain interface, which were investigated in the mutagenesis 
study, in red. [right] A closer look into the interface region between the pore and the extracellular domain of two 
adjacent subunits, the investigated loops were labeled accordingly. 
A multiple sequence alignment of prokaryotic and eukaryotic pLGICs (Figure 21) 
illustrates that, despite the low overall sequence identiy (below 30%), residues of the 
domain interface are highly conserved. For example the motif of DXRXZPFDXQ (single 
letter code; Z = any aromatic residue) in the β6 - β7 loop, (the cys-loop), and the arginine 
of the β10 - α1 linker are conserved throughout the family ( red boxes in Figure 21). 
 
- 42 - 
 
Figure 21: Sequence alignment of the prokaryotic homologues GLIC (top), ELIC (middle) and the eukaryotic 
mouse α7 nicotinic Acetylcholine Receptor (α7 nAChR). All proteins are from the cation selective branch of the 
pLGIC family. The red boxes indicate the interface region on which this study has focused. The conservation 
within the sequence is indicated as follows: In red boxes and white font (X) are the residues which are conserved 
in all three homologues. In red letters (X) are the conserved residues in two homologues. In blue boxes are stretches 
of at least two conserved residues. 
Initially, I have made alanine point mutants of interface residues and studied these mutants 
in Xenopus laevis oocytes. For that purposed complementary RNA (cRNA) transcribing 
the mutant proteins with an N terminal hemagglutinin (HA) fusion tag was injected into the 
oocytes. The surface expression levels of the tagged channels were detected and quantified 
by immunolabeling methods (ELISA (66)) using an antibody recognizing the HA-tag. The 
signals for each mutant was subtracted from the background obtained from uninjected 
oocytes and normalized to the expression signal of WT. For comparison background and 
WT were quantified with every round of measurements. In this analysis most mutants 
showed robust surface expression in both ELIC and GLIC and only for few positions the 
surface expression was strongly decreased (smaller than two and a half times over the 
background, Figure 22 for GLIC (top) and for ELIC (bottom)). 
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Figure 22: Surface expression of different mutants of GLIC (top) and ELIC (bottom). The signals were normalized 
to WT (left). Averages are from at least three independent measurements, with the standard error (SEM) shown 
in black bars. The majority of the mutants show robust expression levels. Mutants that are weakly expressed 
(<=2.5x background signal of an empty oocyte) are labeled in red. 
In GLIC, the low expressing mutants were: D121A, T124A and T157A (Figure 22 top). 
Interestingly the D121, of the cys-loop, concerns a conserved residue involved in the 
proposed ‘principal pathway of gating’. The role of T124, of the cys-loop, is not obvious, 
as it does not have any direct interaction partner and its side chain is pointing into the 
solvent away from the protein. The T157 of the β8 - β9 loop does also not have a direct 
interaction partner, but it is in close vicinity of the β1 - β2 turn (Figure 23 left), which might 
be important. 
In ELIC the mutant E159A showed only weak signal and was therefore considered to be 
non-expressing. This mutant is located in the β8 - β9 loop and points towards the internal 
vestibule of the extracellular domain where it faces the α2 - α3, the β10 - α1 and the β2 - 
β3 loops and could thus play role in the activation process. 
Low expression in mutants of ELIC was found at following positions: R117A, F119A, 
W160A, P254A and Y258A (Figure 22 bottom). In most cases the location of the residue 
provides a possible cause for the decreased expression. R117 of the cys-loop is pointing 
away from the extracellular domain into the solvent and has thus no obvious importance in 
subunit-subunit or any other protein interaction. F119 is a conserved hydrophobic residue 
in the cys-loop, which points into a hydrophobic core between the β1 - β2 and the cys-loop, 
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which might be very important for protein stability. W160 is a conserved hydrophobic 
residue of the β8 - β9 loop which points towards the β10 - α1 linker and the cys-loop. P254 
is a conserved residue of the only pore loop, the α2 - α3, in the interface region, which has 
been proposed to be important in channel opening (5, 46). And the Y258 is a conserved 
residue in the α2 - α3 loop, which point towards the hydrophobic core of the β1 - β2 and 
the cys-loop (Figure 23 right). 
 
 
Figure 23: Position of the low expressing alanine mutants in GLIC (left) and ELIC (right). The channels (GLIC 
and ELIC) are shown in ribbon representation, the mutants are labeled and shown as sticks (red). 
 
After analyzing the expression of mutants on the surface of the oocytes, experiments were 
performed to test their ability to activate and thus to from a functional channel. For this 
reason oocytes were again injected with cRNA encoding the mutated channel fused to an 
N-terminal HA-tag and additionally studied by two-electrode voltage clamp (2EVC) 
experiments. For this the oocytes were clamped at a holding potential of -50 mV, while the 
evoked current over the membrane after the application of high concentrations of the 
agonist was measured. The agonist concentrations (5 mM and 25 mM cysteamine for ELIC 
and pH 4 and pH 3.5 for GLIC) were chosen to also activate mutants which require higher 
concentrations of the ligand for compared to the WT channel (Figure 24). After the 2EVC 
recording, the surface expression of the channel on the same oocyte was detected. These 
experiments gave an overview about which mutants are still able to activate and for those 
not being able to activate to see whether they are present in the membrane of the oocyte. 
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Figure 24: 2EVC activation experiment of ELIC mutants. The holding potential was -60mV. To analyze whether 
the mutated channels expressed on the surface of the oocytes can still be activated, two different concentrations (5 
mM and 25 mM) of the agonist cysteamine (cys) were applied and the evoked current over the membrane were 
recorded. Two mutants (F122A and the F117A) are shown as an example. While the mutant F122A still activates, 
the mutant F117A does not even show residual currents despite its robust surface expression and was therefore 
labelled as ‘loss of function’. 
 While most mutations showed activation similar to the WT channel, few mutations showed 
no or only residual response upon agonist application (Figure 24 and Table 1), despite being 
expressed on the surface of the oocyte. As these ‘loss of function’ mutants are not in the 
vicinity of the ligand binding domain, the signal transduction from ligand binding to the 
pore opening might be interrupted. 
 
loop GLIC ELIC 
β1 - β2 D31A  
    
cys F115A F116A 
 R117A  
 Y118A F119A 
 P119A P120A 
 F120A  
 D121A D122A 
    
α2 - α3 L249A L253A 
 T252A L256A 
 Y254A Y258A 
 
Table 1: ‘Loss of function’ mutants in both homologues, which show no or only slightly above residual currents 
upon agonist application. The mutants are grouped according to their location in the protein. Equivalent positions 
in ELIC and GLIC are in the same row of the table. This data indicate a similar behavior between the two proteins 
in seven out of ten positions. 
No mutation was identified where the channel has shown large basal activity. In most 
positions ELIC and GLIC had a similar phenotype, but there are some residues where 
differences between the two homologues could be observed. The mutation D31A in GLIC, 
for example, does not activate anymore, while the mutation of the equivalent position in 
ELIC, a threonine, can still be activated. In both homologues most residues which lead to 
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an inactive channel were found in the cys-loop and the loop connecting helices α2 and α3 
in the pore region (Table 1 and Figure 23). 
For the cys-loop the conserved ‘loss of function’ positions are residues which either change 
the flexibility of the loop (ELIC Pro120, GLIC Pro119), bulky hydrophobic residues (ELIC 
Phe116, GLIC Phe115 and ELIC Phe119, GLIC Tyr118) or charged residues (ELIC 
Asp122, GLIC Asp121). The hydrophobic residues point into a tightly packed hydrophobic 
core between the cys-loop and the β1 - β2 turn. The charged Asp residue is part of the 
‘principal pathway of gating’, where it forms a conserved salt bridge with an Arg of the 
β10 - α1 linker. 
In the α2 - α3 loop, three residues could be found which are pointing towards the same 
hydrophobic core of the cys-loop and the β1 - β2 turn: The (ELIC Leu253, GLIC Leu249), 
the (ELIC Tyr258, GLIC Tyr258) and a non-conserved residue (ELIC Leu256, GLIC 
Thr252). 
 
 
Figure 25: Position of ‘loss of function’ mutant. (left) Superposition of ELIC (brown) and GLIC (green) in ribbon 
representation with the interface loops labeled accordingly. The positions of the ‘loss of function’ mutants are 
highlighted in red. (middle) Ribbon representation of GLIC (green) with the ‘loss of function’ mutants shown as 
sticks (red) and labeled accordingly. (right) Ribbon representation of ELIC (brown) with the ‘loss of function’ 
mutants shown as sticks (red) and labeled accordingly. 
Overall the experiments showed a similar activation pattern for mutations in both 
homologues. This behavior is particularly pronounced for the ‘loss of function mutants’ 
thus underlining that these positions may be critical for the transduction of conformational 
changes between the two domains. Furthermore, the results underline the high structural 
and functional conservation in these loops, which indicates a similar gating mechanism of 
the two proteins that is likely conserved within the entire family (Figure 21 and Table 1). 
 
2.2.2 Characterization of non-activating mutants in the domain interface 
The ‘loss of function’ mutants where subsequently investigated whether they are still able 
to fold properly. For this purpose, the proteins were expressed in E. coli with a cleavable 
N-terminal expression and purification tag (33, 40, 49, 50). Equivalent amounts of cells 
were used for purification of each mutant. After extraction in the detergent n-dodecyl-β-D-
maltoside (DDM) and affinity purification on Ni-NTA, the N-terminal tags of the proteins 
were cleaved and removed by an additional Ni-NTA purification step. Subsequently each 
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mutant was subjected to size exclusion chromatography. The protein was detected by 
recording of its tryptophan fluorescence (excitation: 280 nm, emission: 320 nm). The peak 
height of each mutant at the corresponding elution volume was then compared to the peak 
height of the WT protein (Figure 26). Most mutants could be expressed, purified and were 
stable in detergent solution, thus indicating proper folding. 
 
 
Figure 26: (a) Expression and stability test of ELIC mutants. In this picture the behavior of two mutants (Y258A 
and P120A) is illustrated. The curves show the recoded Trp fluorescence of each protein during their elution from 
a G3000SWXL gel-filtration column. For each mutant the peak height at the elution volume (red line at 9.8 ml) 
was used for analysis. (b) Table of all investigated mutants of GLIC (left) and ELIC (right). The mutants, which 
showed significant decrease in expression and stability, were highlighted in red. 
From the entire set of positions only two mutants replacing a conserved proline and 
aspartate in the cys-loop showed significant lower expression and stability in both 
homologues (Figure 26 b). 
Structural studies were undertaken in order to investigate whether these ‘loss of function’ 
mutants might reveal their inability to activate on a structural level. In ELIC, the mutants 
F119A of the cys-loop and L256A of the α2 - α3 loop did not show any crystals in initial 
attempts. For the F116A of the cys-loop and the Y258A of the α2 - α3 loop data sets were 
collected, which both allowed structure determination at 3.5 Å and 3.2 Å respectively. In 
both cases, the protein crystallized in the same non-conducting conformation that has been 
observed in all currently determined ELIC structures (49, 58, 67-69). This emphasizes the 
stability of this state in detergent solution. Small differences in loop conformations in the 
vicinity of the mutations indicate a local rearrangement of protein interactions. In the 
F116A mutant, the adjacent β1 - β2 turn moved into the position, which was previously 
occupied by the bulky phenylalanine (Figure 27). This small change could nevertheless 
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explain the loss of function, since the β1 - β2 turn moves further away from the α2 - α3 
pore loop. The interactions between the β1 - β2 and the α2 - α3 loop have been indicated in 
several studies as important determinant of channel activation (5, 6, 46, 57, 62, 70). 
 
Figure 27: [left top] 2Fo-Fc Electron density (blue mesh, contoured at 1.5 σ) of the refined ELIC mutant F116A 
mutant superimposed on the model of WT (PDB 2VLO, red). The electron density clearly indicates the loss of the 
Phe side chain whereas the rest of the cys-loop remains unchanged. The adjacent β1 - β2 turn does not fit into the 
density of WT. [left bottom] The refined model of F116A accounts for the conformational change of the β1 - β2 
loop. [right] Superposition of the ELIC WT (red) and the F116A (blue) mutation in ribbon representation. The 
mutated amino acid is shown in sticks and its van der Waals Radii as dotted spheres. It is visible that upon mutation 
the β1 - β2 turn moves into the space previously occupied by the F116, while the cys-loop remains unchanged. 
 For the mutant Y258A, in the α2 - α3 loop, a different picture was obtained. There, both 
loops, the α2 - α3 and the β8 - β9 loop, which in WT are in close proximity have moved 
apart from one another (Figure 28). The changes in this mutant emphasize the interaction 
of the pore-domain loop with the β8 - β9 loop and it suggests that upon interruption of this 
interaction, the channel loses its ability to open. Both structures emphasize that the interface 
contains a tight network of interactions where even slight changes lead to drastic effects. 
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Figure 28: [left top] 2Fo-Fc electron density (blue mesh, contoured at 1.5σ) of the Y257A mutant around the α2 - 
α3 loop superimposed on ELIC WT (2VLO, red). The loss of the side chain of Tyr258 t in the density is apparent. 
The poor fit of the loop indicates a local structural rearrangement. [left bottom] Refined model of Y258A (green). 
[middle top] Conformational changes around the β8 - β9 loop. WT does not interpret the density correctly, while 
in the refined Y258A structure the fit has improved (middle bottom). [right] Superposition of ELIC WT (red) and 
the mutation Y258A (green) in ribbon representation. The mutated amino acid is shown in sticks and its van der 
Waals Radii as dotted spheres. The α2 - α3 loop and the β8 - β9 loop slightly move away from one another, as if a 
connection was broken. 
 ELIC 
Y258A 
Data collection  
Space group P21 
Cell dimensions  
a, b, c (Å) 105.0, 
266.4, 
110.0 
 () 90.0, 
110.4, 
90.0 
Resolution (Å) 50–3.2 
Rmerge* 8.3 (67.5) 
I / I * 11.2 (2.2) 
Completeness (%) * 99.9 (98.8) 
Redundancy * 3.9 (3.2) 
  
Refinement  
Resolution (Å) 30–3.2 
 
No. reflections 93222 
Rwork/ 
Rfree 
22.8/ 
27.5 
No. atoms  
Protein 24,950 
Ligand/ion  
B-factors  
Protein 83.2 
Ligand/ion  
R.m.s. deviations 10.9 
Bond lengths (Å) 0.01 
Bond angles () 1.36 
                                                                                      *Values in parentheses are for highest-resolution shell. 
Table 6: Data collection and refinement statistics for the ELIC mutant Y258A. 
Despite broad screening of conditions, no crystals diffracting to high resolution were 
obtained for the corresponding mutants in GLIC.  
The structural data in ELIC demonstrate that the mutations, despite their severe phenotype 
on channel activation, have only a local effect on the protein conformation. To exclude that 
the two non-activating mutations in ELIC have compromised the ability of the protein to 
bind its ligand, we have studied agonist and antagonist binding by isothermal titration 
calorimetry (ITC). For this purpose we have purified the protein at a similar scale as used 
for structural studies. In an ITC experiment the heat exchanged in response to the addition 
of a ligand to the purified channel is measured. The measurement is corrected by the heat 
exchange upon addition of the ligand to the buffer not containing any protein. The 
integrated heat per injection of ligand is plotted against the molar ratio of the protein to the 
ligand and fitted to a single-site binding isotherm which allows the quantification of the 
binding affinity (KD).  
The single-site binding isotherm and only a part of the titration curve were used to account 
for the limitations of the data due to the low binding affinities, which are in the mM range. 
For such a low affinities the protein concentrations needed for an accurate characterization 
of binding are beyond reach. 
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Figure 29: ITC experiment characterizing the binding of the agonist propylamine (left) and the antagonist 
acetylcholine (right) to ELIC WT. The exchanged heat upon addition of small aliquots of agonist or antagonist 
was measured (top). The (corrected) integrated values were plotted against the molar ratio between ligand and 
protein and fitted to a single-site bindinge isotherm (bottom). 
To increase the signal of the ITC measurement, the calorimetry experiments were carried 
out in the background of the mutant R91A of the ligand binding site. This mutant has 
previously been shown to increase the binding affinity for the agonists cysteamine and 
propylamine (58) and the competitive antagonist acetylcholine (67).  
 
 
Figure 30: ITC binding experiment on propylamine (left) and acetylcholine binding (right) to the ELIC mutant 
R91A. The heat exchanged by addition of aliquots of the respective substances are shown (top). The corrected 
integrated binding energy plotted against the molar ration between ligand and protein and fitted with a single-
binding site isotherm is shown on the bottom. 
The results of the ITC experiment can then be compared to results obtained from 2EVC 
dose response experiments. In these experiments the oocyte is exposed to increasing 
amounts of agonist concentrations (Figure 31). The evoked currents, normalized to the 
maximally evoked current, is then plotted against the agonist concentration and then fitted 
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to a Hill-function. The concentration, which evokes half maximal currents is termed EC50. 
The fit shows a high cooperativity for ligand activation in both homologues. 
 
Figure 31: The current response of ELIC R91A upon application and washout of propylamine was recorded at       
-60 mV with the two-electrode voltage clamp technique. The application of propylamine at the respective 
concentration is indicated above (black bar). The relative open probability (I/Imax) plotted as a function of the 
ligand concentration is shown below. The currents were normalized to the maximum at saturating ligand 
concentration (i.e., 0.25 mM). Each data point comes from the average of 5 oocytes, their standard deviations are 
shown in black bars. The solid red line shows a fit to a Hill equation with a coefficient of 2.71, with an EC50 of 0.05 
mM. 
 In the ITC experiment of the mutant R91A the agonist propylamine binds with a binding 
affinity (KD) of 1.1 mM, while the EC50 of the 2EVC studies is 0.05 mM (Figure 31). 
Therefore, the EC50 is 20 times lower than the KD measured by ITC. This difference arise 
from the fact how both quantities are related to one another and reflect the initial binding 
of the ligand and the induced conformational change (‘Activation of pLGICs’ 1.3). The 
weak affinity measured in the ITC experiment suggests that the protein in detergent solution 
has an efficacy of around 19 (for WT and R91A, EC50 from 2EVC measurements in 
oocytes), which is rather low then the proposed 130 from electrophysiological experiments 
for the WT channel in HEK cells (71). 
The KD of the competitive antagonist acetylcholine can then directly be measured in 2EVC 
experiments. In these experiments the displacement of the dose response curve of the 
agonist upon increasing concentration of antagonist is measured, which can be analyzed 
with the Schild plot to obtain the KD for the inhibitor. For the antagonist acetylcholine in 
the 2EVC experiment a KD of 0.2 mM was measured (67). Also the binding affinity of the 
antagonist is not in the same order of magnitude as the measured KD (2.6 mM) of the ITC 
experiment. The differences in equivalent quantities obtained by measurements with two 
different techniques underlines that the energetics of binding are different in a lipid or 
detergent environment. Despite these discrepancies, ITC is still a valuable method to 
characterize ligand interactions of the non-activatable mutants. When characterized by this 
method in the background of the R91A mutant both non-activatable mutants, F116A and 
Y258A, show a similar KD for the agonist propylamine antagonist acetylcholine as the 
R91A mutant (Figure 32) , which indicates that the mutations do not alter the binding of 
the ligand, but are disrupting channel activation. 
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Figure 32: (a) Propylamine (left) and the acetylcholine binding (right) to the ELIC double mutants R91A/F116A 
(b) and R91A/Y258A (c) as quantified by ITC. Analysis is as in Fig. 29. 
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2.2.3 Conserved branched salt bridge 
Similar to the phenylalanine of the ‘loss of function’ mutant in the cys-loop, the mutation 
of an equally conserved aspartate residue in the same region (Asp122 in ELIC and Asp121 
in GLIC) results in a complete loss of function in both homologues. Only a conservative 
mutation to glutamate can restore channel function in both homologues (Figure 33 for ELIC 
(left) and for GLIC (right)). This residue is located one layer of amino acids above the 
interface and forms a salt bridge with a conserved arginine residue (GLIC Arg191, ELIC 
Arg199) at the end of β-strand 10 at the boundary to the α1 helix of the pore domain. The 
mutation of this residue to alanine did not show any ligand-induced currents in 2EVC 
experiments whereas the conservative mutation to lysine can restore channel function in 
both homologues (Figure 33 for ELIC (left) and for GLIC (right)). 
 
 
Figure 33: Dose response curves of ELIC (left) and GLIC (right) mutants from at least 5 oocytes, the standard 
deviation is shown in bars in the color of the corresponding mutant. (left) In ELIC the only mutations of the two 
residues D122 and R198, which can restore channel activation are the conservative mutations D122E (red) and 
R199K (blue). WT (black) is shown as a reference. (right) In GLIC the only mutations of the residues D31, D122 
and R198 which can restore channel activation are D35N (blue), D35E (pink), D121E (green) and R191K (red). 
WT (black) is shown as a reference. 
In GLIC Arg191 also interacts with Asp31 on the β-strand 2, a position that is conserved 
in many cys-loop receptor subunits, but not in ELIC where the respective residue is a 
threonine (or GluCl where it is a valine). Although in GLIC D31A is expressed on the 
surface of the oocytes (Figure 22), this mutation prevents channel activation (Table 1). Only 
the mutation of this residue to asparagine or glutamate can restore the function of the 
channel (Figure 33 right).  
When mutating Thr28 in ELIC to aspartate, the residue present in most family members, 
the EC50 of channel activation shifts to a 20 time lower agonist concentration (Figure 35). 
To investigate whether a similar shift in binding affinity is observed in detergent solution 
ITC experiments were performed. However, due to its poor stability the mutant T28D could 
not be purified in the background of the R91A mutation. Therefore in this experiment only 
the single mutant T28D was measured. As observed in electrophysiology experiments also 
the ITC experiments of the mutant show a higher binding affinity. In this case the measured 
KD for the agonist proylamine was 90 µM (Figure 34), which is ~100 times lower than the 
KD of WT (KD 8 mM, Figure 29). Remarkably in 2EVC experiments the T28D mutant led 
only to 20-fold reduction of the EC50 (Figure 35). In contrast to the agonist the KD of the 
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antagonist acetylcholine changed only marginal in comparison to WT (2 mM T28D vs. 2.5 
mM WT; see Figure 34). 
 
 
Figure 34: Propylamine (left) and the acetylcholine binding (right) to the ELIC double mutant T28D as quantified 
by ITC. (a) Summary of results. (b) Thermograms (top) and integrated thermogram peaks and fit (bottom). 
Analysis is as in Fig. 29. 
 
The results indicate that the mutated channel may have improved properties to change its 
conformation in detergent solution. This assumption is based on the fact that the antagonist 
binding in WT and the T28D mutant does not induce any conformational change leading 
to channel activation, as seen in the ITC experiments (KD for WT and T28D mutant are in 
the same range). For the agonist on the other hand a much higher KD in the ITC experiments 
is measured for the mutant. Thus showing that the underlying changes upon agonist binding 
are to a certain degree accessible to this mutant. 
 
Additional mutations to analyze the importance of this position for binding showed that 
corresponding mutations in ELIC have a weaker effect than in GLIC. While in GLIC, D31A 
leads to a loss of function in ELIC, the equivalent mutation T28A is still functional, but 
increases the EC50 by a factor of 10. The mutations of Thr28 to aspartate or asparagine led 
to a shift of the EC50 to higher affinity, while the mutation to glutamate, a larger and side 
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chain, has shifted the EC50 to a lower affinity (Figure 35). This suggested that the 
interaction is not only based on the coulumbic interactions, but also on the size of the 
residue, with the larger glutamate disturbing the interaction. 
In ELIC the reversal of the charges (T28R and R199D) restores the current response upon 
agonist application, thus emphasizing the importance of this interaction for the transduction 
of conformational changes during channel activation. 
 
Figure 35: Dose response curves of Thr28 mutants of ELIC mutants from at least 5 oocytes, the standard deviation 
is shown in bars, which is part of the ‘principal pathway of gating’. The experiments show a clear indication for a 
very strong interaction between the Arg191 and the residue present in position 28, which is dependent on the 
charge and the size of the respective side chain. 
 
2.2.4 Mutagenesis of the contact region between the β1 - β2 turn and the α2 - α3 loop. 
A substantial part of the domain interface is formed by the interaction of the backbone of 
the residue at the tip of the β1 - β2 turn with the ring of a strictly conserved proline residue 
in the α2 - α3 loop. This interaction is observed in the open structures of GLIC and GluCl, 
but not in the non-conducting structure of ELIC, where this contact is broken (5, 6, 49, 50). 
It was suggested that this interaction may play an important role in the activation cycle (5). 
To investigate the proposed role of this interaction for channel activation I have studied 
mutations on this conserved proline by X-ray crystallography and electrophysiology. The 
results show that the mutation of this proline to alanine does still lead to channel activation 
in both proteins, with a slightly changed EC50 (Figure 40). In line with the small effect in 
functional experiments, the crystal structure of the P250A mutant in GLIC, which was 
determined at 3.2 Å (for statistics see Figure 36) only shows minor deviations in 
comparison to the respective WT (Figure 36). 
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Figure 36: [left] 2Fo-Fc electron density (blue mesh, contoured at 1.5σ) of the P250A mutant superimposed models 
of WT and the refined structure of the mutant. [middle] superposition of the WT (green) and the P250A (orange). 
There are no strong differences between the two models observed, thus indicating that both structures adopt a 
very similar conformation. (right) Data collection and refinement statistics for the GLIC mutant P250A. 
To remove any potential side chain interaction to the ligand-binding domain, the proline 
was in both channels mutated to the shortest and most flexible amino acid glycine. In ELIC 
the mutation P254G has only a comparably small effect on the structure, which overall 
shows the frequently observed non-conducting conformation with a small reorganization 
of the well-structured α2 - α3 loop (Figure 36). 
 
Figure 37: (left) 2Fo-Fc electron density (blue mesh, contoured at 1.5 σ) of the P254G mutant superimposed on the 
models of WT (red) and the P254G mutant (orange) in ribbon representation. The α2 - α3 loop of the mutant 
undergoes a structural rearrangement. (middle) Superposition of one subunit of the WT structure (PDB code 
2VLO) in red and the mutant P254G in orange. The overall structural elements are identical, only a change in the 
α2 - α3 loop is apparent. (right) Data collection and refinement statistics for the ELIC mutant P254G. 
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The equivalent mutation P250G in GLIC resulted in large rearrangements of the pore when 
compared to the WT structure. The structure was determined at 3.3 Å and shows a molecule 
with small differences for most of the protein except for the α2 - α3 loop and the pore-lining 
helix α2, which both have undergone major conformational changes. The introduced 
flexibility by replacing the least flexible with the most flexible amino-acid has resulted in 
the rearrangement of the α2 - α3 loop and the unfolding of the C-terminal part of the helix 
α2. The remainder of the helix collapsed towards the pore axis. 
 
 
Figure 38: [left] Superposition of GLIC WT (PDB code 3EHZ) in green and the P250G mutant in brown. The 
front subunits are removed to allow the view into the pore region. Although the largest part of the structure is 
unchanged, the pore lining α2 helix and the α2 - α3 loop have undergone a large conformational change. (middle 
top) 2Fo-Fc the electron density (blue mesh, contoured at 1.5 σ) of the P250G mutant superimposed on a subunit 
of WT and the P250G mutant. The rearrangement of the α2 - α3 loop and the α2 helix is apparent. (middle bottom) 
Side view of a superposition of a single subunit of WT and the P250G mutant. (right) Data collection and 
refinement statistics for the GLIC mutant P250G. 
This collapse has maximized the hydrophobic interactions of residues at the extracellular 
part of the helix leading to a pore, which is most probably impermeable to ions.  
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Figure 39: Pore lining helices α2 of WT (left, green) and the P250G mutant (right, brown). The blue mesh shows 
the water accessible surface of both pore regions.  
In contrast to the extracellular half of the pore-forming helix, the conformation of its 
intracellular half is unchanged compared to the WT structure. Remarkably, this 
conformation is very similar to the previously reported structures of GLIC obtained by 
different methods (62, 63). In one study cysteine residues were introduced into the interface 
of the β1 - β2 and the α2 - α3 loop. Upon crosslinking, GLIC adopted a distorted 
conformation in this region, which closely resembles the structure of the P250G mutant. 
This distortion was assigned to a locally closed conformation of the ion conduction path. 
In the second study the structures of two non-activating mutants in the α2 - α3 loop, i.e. 
T252A and Y254A, were described. The same functional phenotypes for these mutants 
were also identified in the present study. 
Remarkably, despite the strong impact of the mutation on the respective structure, the 
proline to glycine mutants of both homologues can still be activated. 
 
When studied by 2EVC, the GLIC mutant P250G was activated with an EC50 that was 
shifted by 0.5 pH units towards higher proton concentration (Figure 40). To compare the 
surface expression and the maximally evoked currents for the mutant and WT, the current 
of each oocyte in response to saturating agonist concentrations was first measured by 2EVC 
and subsequently related to the ELISA signal quantifying the relative expression levels. 
Despite the strong surface expression of the mutant, the amplitude of the maximally evoked 
current was by a factor of three lower than typically observed for WT (Figure 40), which 
indicates differences in either the conduction or gating properties of the P250G mutant. 
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Figure 40 [left] GLIC dose response curves of the α2 - α3 and β1 - β2 loop mutants from at least 5 oocytes, the 
standard deviation is shown in bars. The tip mutant K32A has a similar EC50 than the WT, while the Glycine 
substitution at the same position leads to a higher EC50. The α2 - α3 loop mutants at the position Pro250 show that 
the alanine mutant opens at lower proton concentrations than WT, whereas the Glycine mutation is shifted 
towards higher proton concentrations. [right] Maximally evoked currents of the GLIC P250G mutant and WT 
relative to the surface expression of the channels. The current density of the mutant P250G is significantly less 
than for the WT channel. 
For ELIC, the mutation at the same position (P254G) is activated with similar EC50 as WT 
(Figure 42). Despite the apparent similarity in the potency of the agonist an unfamiliar 
phenotype was observed in the macroscopic 2EVC recordings. In these recordings the 
currents did not decrease with similar time dependence upon washout of the ligands as in 
WT. Sustained currents that slowly decreased were instead observed for a prolonged 
amount of time. (Figure 41). 
 
Figure 41: Channel activation and deactivation measured by 2EVC at a holding potential of -60mV. Both WT 
(left) and the mutant P254G (right) were exposed to 5 mM of the agonist cysteamine. Once the current maximum 
for this concentration was reached the agonist was washed out by diffusion with agonist-free solution. The WT 
shows a rapid decay of currents, whereas in the mutant the closing rate appears strongly reduced.  
In contrast to the equivalent mutant of GLIC, the P254G mutant in ELIC showed higher 
maximal currents per surface expressed channels than WT (Figure 42). 
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Figure 42: [left] ELIC dose response curves of the α2 - α3 and β1 - β2 loop mutants from at least 5 oocytes, the 
standard deviation is shown in bars. The tip mutant L29A has a lower EC50 than the WT, while the deletion of the 
residue (woL29) leads to a similar EC50. The α2 - α3 loop mutants at the position Pro254 show that the alanine and 
glycine substitutions open at similar concentrations as WT. [right] Maximally evoked currents of ELIC mutants 
and WT normalized to the surface expression quantified immunolabeling. The mutant P254G shows a tendency 
for higher surface densities than the WT channel. 
A maximally evoked current higher than the WT channel has previously only been 
observed upon addition of positive allosteric modulators (PAM), which abolish or slow 
down desensitization (72).  
The cause for the unusually slow deactivation was revealed after a closer inspection on the 
structure of the P254G mutant. Next to the distortion of the α2 - α3 loop, the electron density 
showed that the side chain of the close by Arg255 has changed its conformation observed 
in WT and instead points away from the pore into the region of the β8 - β9 loop of an 
adjacent subunit. On this loop it interacts with a glutamate residue at position 159 (Figure 
43). This interaction, which is was not observed in the WT underlines the slowed 
deactivation of this mutant. Remarkably E159A was previously identified not to be 
expressed (4 ± 2 % surface signal compared to WT expression, Figure 26). Which indicates 
its importance for the folding of the protein. 
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Figure 43: [left] 2Fo-Fc electron density (blue mesh, contoured at 1.5σ) of the P254G mutant superimposed on the 
model of WT (red) and the P254G mutant (orange). The Arg at position 255 has changed its conformation as 
visible in the electron density and now faces the β8-β9 loop. [right] Superposition of WT and P254G model. The 
residues E159 and R255 are shown as sticks. 
For the double mutant P254G/R255A, the macroscopic 2EVC measurements showed WT-
like closing and a ligand dependence of channel activation that shifted towards lower 
agonist concentration (Figure 44). Also the single mutant of R255A behaved similar as WT 
in macroscopic 2EVC measurements (Figure 44). These results confirm the role of this 
positively charged Arg255 residue in the unusual deactivation phenotype of the P254G 
mutant. 
 
Figure 44: Dose response relationships of ELIC mutants of the α2 - α3 loop as measured by 2EVC mutants from 
at least 5 oocytes, the standard deviation for each data point is shown in bars in the corresponding color. 
Despite the strong conservation of the proline residue in the α2 - α3 loop and the observed 
interaction with the extracellular domain in the open state of the channel, the mutation of 
the position to glycine do still promote channel activation in both ELIC and GLIC. 
To further probe the importance of the interaction between the β1 - β2 turn to the α2 - α3 
loop, additional mutants were constructed. The β1 - β2 loop was shortened by removal of 
the interacting residue in GLIC (i.e. Lys32) and the corresponding position in ELIC (i.e. 
Leu29). The deletion mutants woK32 in GLIC and woL29 in ELIC where then 
characterized with respect to surface expression and dose dependence of channel opening. 
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In GLIC, this mutant showed severely reduced channel activity with a midpoint of 
activation that is shifted to higher proton concentration (Figure 45). 
 
Figure 45: 2EVC dose response experiment. GLIC WT, the mutant woK32 and an uninjected oocyte were exposed 
to different proton concentrations. While the WT channel shows robust currents with a maximum around pH 4.5 
(top), currents in the woK32 mutant (middle) increase even at higher proton concentration (pH3.5). The currents 
in this mutant are low (please note the different scale for the recordings), but significant above an uninjected, 
oocyte (bottom). The comparison was made with oocytes which show similar expression levels of the channel. 
 
 The equivalent mutation in ELIC exhibited a slightly lower EC50 as the WT channel, with 
reduced maximal current response (Figure 42). Collectively the results on the interaction 
of the β1 - β2 loop of the extracellular domain with the α2 - α3 loop of the pore domain 
suggest that this interaction contributes to channel activation, but it appears not to be as 
crucial as suggested by the X-ray structures. 
  
- 63 - 
  
- 64 - 
3 Discussion 
Pentameric ligand-gated ion channels (pLGICs) have been studied extensively for decades. 
In the beginning, these studies were limited to functional investigations of eukaryotic 
family members by biochemical and electrophysiological methods. The identification of 
prokaryotic homologues and the availability of their structures at high resolution, opened 
the door for detailed structure-function experiments. Nevertheless it remained a difficult 
task to deduce a molecular mechanism that relates the available functional data measured 
on eukaryotic proteins to the structural features of their prokaryotic homologues. Only in 
the last few years functional data became available for prokaryotic pLGICs of known 
structure.  
In recent studies the first step of the activation mechanism, the binding of the ligand to a 
site in the extracellular domain has been described in the context of the full-length protein 
(6, 18, 69). The structural data in general agreed with previous made in the AChBP, which 
resembles the extracellular domain of the nAChR, and which so far was used as a model to 
describe agonist and antagonist binding.  
The next step of the activation process requires the conformational change in the 
extracellular domain upon ligand binding to be transmitted to the pore region, where it leads 
to channel opening. The underlying mechanism of this step is still under debate. One reason 
for the controversial discussion of the activation mechanism is that any structural 
information on different conformations of the channels have been obtained from different 
homologues and that most of the functional data, were obtained from family members with 
non or limited structural information. 
 
To investigate whether the potential open conformation of GLIC seen in the crystal 
structure does indeed resemble a conductive state, known inhibitors of the nAChR were 
used to investigate the pore properties. These inhibitors bind to the open pore from the 
outside and thereby block the ion flow through the channel of nAChRs. This study revealed 
the structural basis of open channel block in the pLGIC family and confirmed the 
hypothesis that the structure of GLIC shows an open conformation. 
In the second part of the thesis I have studied the proposed pathway of activation of pLGIC 
family in the two prokaryotic homologues ELIC and GLIC. These studies confirmed the 
importance of stretches of conserved residues in the domain interface region of the 
extracellular and pore domain for the transduction of conformational changes.  
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3.1 Modulation of pLGICs 
3.1.1 Open pore block 
With a known structure of its potential open state the prokaryotic pLGIC GLIC became an 
ideal model to study the effect of open pore blockers. The study revealed that the same set 
of molecules inhibiting the currents in nAChR also act on GLIC by a similar mechanism. 
These pore blockers include quaternary ammonium compounds, local anesthetics and 
divalent transition metal ions. By a combination of electrophysiological and structural 
studies two distinct interaction modes of the open pore blockers with the pore could be 
revealed. 
 
 
Figure 46: Schematic representation of the interaction of the funnel shaped open pore with the open pore blockers 
of GLIC. The pore lining helix α2 (cylinder) is color coded depending of the properties of the pore facing residues 
(yellow: hydrophobic; green: polar; red: charged). Two distinct binding areas could be distinguished: The bulky 
monovalent quaternary ammonium compounds and local anesthetics block the channel at the boundary between 
the hydrophobic and polar part, whereas the divalent transition metal ions directly interact with the negatively 
charged residues at the intracellular end of the pore. 
One area of interaction is located at the boundary between the hydrophobic and polar parts 
of the funnel-shaped pore. The studies showed that bulky monovalent open pore blockers 
are attracted to the channel by their net charge, but that they are too big to pass the channel 
constriction. The exact binding position is dependent on the size of the molecules, with 
smaller blockers binding deeper in the pore. Similar observations were previously made for 
open pore blockers of the nAChR (20). Our study also demonstrated that the mutation of 
the conserved negatively charged ring, which in nAChR was termed the ‘intermediate ring 
of charge’, has an effect on the binding affinity of the blocker, but not on its location within 
the pore. Thus it can be concluded that the size and not the electrostatic interactions with 
the only charged area in the pore is determining their binding position. This finding also 
underlines the significance of the ‘intermediate ring of charge’ to attract cations to the 
channel, but it also shows that these residues are not the only factor for cation selectivity 
(54, 73). 
For the second binding site a different mode of interaction was observed. In this case the 
divalent transition metal ion Cd2+ binds to the conserved glutamate residue at the 
intracellular pore exit. The mutation of this position to the uncharged and smaller residue 
alanine removes the block and also abolishes binding, as confirmed in the crystal structure 
of the mutant. The comparably low binding affinity of the impermeant Cd2+ applied form 
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the extracellular side suggests that the block is not due to tight interactions with this site, 
but instead due to a high energy barrier in the translocation path. A tight interaction of 
divalent ions with this conserved ring of negative charges has as well been described for 
the nAChR (74, 75) and was also observed for the conduction of the permeant ion Zn2+ in 
GLIC. In summary it can thus be concluded that the studies on open channel block in GLIC 
agree well with the published data on other family members (20, 76-78). The agreement of 
electrophysiological and structural data of this specific homologue also suggests that the 
structure of GLIC, indeed closely resembles an open state of the channel. 
 
In the course of the study of open pore blockers it was observed that the divalent ions Zn2+ 
and Cd2+ do not only bind in the pore region, but also in the extracellular domain of GLIC. 
Despite the fact that during the investigation of pore block the potential functional 
importance of these additional binding sites was neglected, they are not necessarily 
unimportant. Divalent ions have been shown to modulate pLGICs not only in the pore 
region. In nAChRs modulatory effects of divalent ions have been studied in detail. In these 
channels certain divalent ions had an activating effect at low concentrations and an 
inhibitory effect at higher concentration (79). It was postulated that the positive effect 
originates from an interaction in the extracellular domain, whereas the high concentration 
of the ion leads to pore bock. Additionally divalent ions have been known to interact with 
certain residues in the vestibule of the extracellular domain, which in addition to charged 
residues in the pore region contribute to ion selectivity of the channel (Figure 47 and (80)). 
The residues within the extracellular domain that were identified as important determinants 
of charge selectivity are located at the extracellular entrance (i.e. E64 in ELIC and E72 in 
GLIC) and the center of the extracellular vestibule (i.e. D86 in ELIC and D89 in GLIC). 
With respect to distance and geometry, these residue are in prominent positions to influence 
the electrostatics of the vestibule and thus to function as selectivity screen in the 
extracellular lumen. 
 
Figure 47: Residues important for ion selectivity in ELIC. (left) Table of diameter distances (calculated from α-
carbon distances) including SD values (from five different measurements) of residues important for ion selectivity 
in ELIC. (A) Ribbon representation of ELIC viewed from within the membrane with the front subunit removed. 
Residues predicted to be important for ion selectivity are shown in red. (B) Top view of the first ring of residues 
(E64) involved in the ion selectivity. (C) Homopentamer ELIC with five binding sites for ions, showing the ion 
selectivity sites (Adapted from Hansen et al. (80)). 
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In a study by Zimmermann and colleagues, in which I have participated, the effects of 
divalent ions on permeation and gating in ELIC were investigated (67). In this study, three 
different binding sites for divalent cations were identified. The three sites were named 
according to their location in the channel as Sin, Sout and Spore. Whereas the site Sout was 
linked to the allosteric inhibition of ELIC by divalent cations, the other two sites, Sin and 
Spore, did not participate in any modulatory effect. 
By comparing these binding sites with the sites coordinating divalent ions in GLIC, it was 
remarkable to see that one site in the extracellular domain occupied by Zn2+ was at the 
equivalent position as Sin in ELIC (D68, Figure 47 and Figure 48). This is a location which 
has previously been shown to be important for charge selectivity and conductance, thus 
emphasizing the conservation of functional mechanisms within the family. 
 
Figure 48: (a) Top view of the anomalous difference electron densities of Zn2+ (blue mesh, contoured at 4σ) in 
GLIC WT (green; PDB code 3EHZ), in all five subunits the Zn2+ ion is present. (b) Close view of the binding site 
of Zn2+ in one subunit, it is coordinated by two Aspartate residues (i.e. Asp 86 and Asp 88). (c) Superposition of 
the ELIC WT (light blue; PDB code: 2YN6) crystallized with Ba2+ (Van der Waals radius of the barium ion in 
orange dots) with GLIC WT (green) with the anomalous signal of Zn2+ (blue mesh) at the position of the Sin site, 
an extracellular ion selectivity site. The binding sites of both divalent ions are very close, differences arise from 
local differences in the structure.  
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3.2 An insight into gating 
Before a pLGIC can be blocked by open pore blockers, the channel first needs to be 
activated. The activation within the pLGIC family is initiated by the binding of a ligand to 
a conserved site in the extracellular domain. The following conformational rearrangements 
in this part of the protein are transduced through interactions in the interface to the 
transmembrane part of the protein to activate a selective ion permeable pore.  
During my PhD studies I have investigated how mutations at or close to the interface 
between the extracellular and the pore domain are affecting gating in the two prokaryotic 
pLGICs ELIC and GLIC. I was able to identify residues in a region of high conservation in 
the cys- and the α2 - α3 loop, which, upon mutation, lost their ability to open the channel. 
 
 
Figure 49: ‘loss of function mutants’. (a) Sequence alignment of the cys-loop and the α2 - α3 loop (the color coding 
for the conservation is the same is in Figure 21). (b) List of residues which upon mutation to alanine show a ‘loss 
of function’ phenotype. (c) Superposition of GLIC (green) and ELIC (brown) the location of the loss of function 
mutants are indicated in red. The black arrow indicates the direction of view for panels (d-f). (d) Close-up of the 
interface between the α2 - α3 loop and the cys-loop. (d) Cα trace of GLIC with its ‘loss of function mutants’ shown 
in red. (f) Cα trace of ELIC with its ‘loss of function mutants’ shown in red. 
 
An interesting feature of these conserved ‘loss of function’ (lof) mutants is that, except for 
two residues, they are in both structures (ELIC and GLIC) part of a hydrophobic interface 
between the pore and the extracellular domain. This interface must play an important role 
during the activation cycle. Two residues not involved in this interface are a conserved 
proline and a conserved aspartate of the cys-loop. The proline likely plays a structural role 
in rigidifying the loop, whereas the aspartate is part of a conserved salt bridge of the 
‘principal pathway of gating’ (45). In this proposed pathway of activation a network of 
interactions connects the cys-loop with the β1 - β2 loop via a conserved arginine at the 
transition between the extracellular domain and the pore. 
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Previously an equivalent hydrophobic network as the one identified in our study has been 
proposed by Sine and coworkers (46) to influence gating in the nAChR and termed the 
‘cys-loop pathway’. 
Also there a hydrophobic core of the cys- and the α2 - α3 loop was shown to exert a large 
effect on activation. The residues identified in nAChR were two phenylalanines (F135 and 
F137) of the cys-loop and a tyrosine (Y277) and a leucin (L273) of the α2 - α3 loop. Even 
though in the structure of the nAChR they are at different positions than their equivalent 
residues in ELIC or GLIC a similar functional effect was observed. A reason for the 
discrepancy in structural details could arise from the fact that the nAChR cryo - EM 
structure ((42, 44)) was not determined at sufficiently high resolution to allow the correct 
assignment of residues. Despite the fact that in their study Sine and colleagues have used 
comparably conservative mutations, their results as well emphasize the importance of this 
hydrophobic core at the interface for channel activation, which is in agreement with my 
findings. In my studies I could show that certain ‘loss of function’ mutants, despite their 
drastic effect on channel opening, were still able to bind the agonist in a similar manner as 
WT. This underlines that these mutations did not interfere with ligand binding, but with 
gating. 
Two of the ‘loss of function’ mutants of the α2 - α3 loop of GLIC have recently been 
characterized in GLIC by X-ray crystallography and electrophysiology (63). Despite the 
same effect on gating, the structures of the equivalent mutants, Tyr254 in GLIC determined 
by Gonzalez-Guiterrez et. al. and the mutant at the corresponding position from ELIC (i.e. 
Tyr258), which was determined in this study, are not directly comparable. In the Y254A 
mutant of GLIC the channel was crystallized at low pH and shows a similar conformation 
as the ‘locally closed structure’ determined by the Corringer group or the P250G structure 
in our study. Whereas most of the structure is in a similar conformation, the α2 - α3 loop 
and the pore forming helix α2 have rearranged leading to an occluded pore, which would 
be in agreement with the ‘loss of function’ phenotype of the channel. ELIC in contrast 
showed its common non-conductive conformation also for the ‘loss of function’ mutants. 
Only local changes in the α2 - α3 and the β8 - β9 loop indicate a potential interaction 
between those two loops in the activation mechanism. No change in the β8 - β9 loop was 
observed in any GLIC ‘loss of function’ mutant structures and it therefore remains to be 
shown whether these differences come from different activation mechanisms of the two 
homologues. A remarkable structural feature concerns the structural stability of the α3 helix 
in GLIC, which is found in the same position in all currently published structures. This 
indicates that this helix might not change its position in the activation cycle, different to a 
mechanism proposed earlier by comparison of the ELIC and GLIC structures (5). These 
findings it led to an alternative mechanism for activation, where the α2 helix locally 
unwinds at the extracellular side to close the pore (62). Data supporting this mechanism 
were recently also obtained from a low resolution structure of GLIC crystallized at high 
pH, which showed similar features in the pore region (unpublished data).  
The occlusion of the pore ‘loss of function’ mutants in GLIC (63) was also observed during 
our studies. The P250G mutant from GLIC shows a similar conformational change of the 
pore region. Interestingly though, I have demonstrated in electrophysiology experiments, 
that this mutant can still be activated. 
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Figure 50: Representation of the water accessible surface (calculated with Hollow (81)) in the pore region for GLIC 
WT (green, left), and the GLIC mutants P250G (brown, middle) and Y254A (blue, right). Helices α-2 are shown 
as stick with the front subunit being removed for clarity, the water accessible surface is shown as colored mesh. 
Both mutants show an occluded pore conformation which is impermeable for ions. The pore diameter of the P250G 
mutant (middle) is similar and even slightly smaller than in the loss of function mutant Y254A (blue). 
 
Although the mutant can be activated, I have observed that the P250G mutant has a lower 
maximally evoked current at saturating ligand concentration when compared to WT. This 
finding indicates that the occluded, non-conductive, conformation is in equilibrium with 
the activated state of the channel and thus cause a smaller macroscopic currents. It is hard 
to say whether this locally collapsed state is indeed part of the activation mechanism or just 
a detergent / mutation artefact. Because this state has not been seen in the homologue ELIC.  
In ELIC the equivalent mutation (i.e. P254G) causes a slightly different phenotype. This 
mutant is as well still able to active the channel, but while in GLIC the channel showed a 
smaller maximally evoked current in comparison to WT, in ELIC the maximum current 
was higher. At the same time the channel was shown to be open for a prolonged period of 
time even after the removal of its ligand. The structural data of this mutant showed a 
possible explanation for this unusual phenotype. Despite the fact that the overall structure 
of the ELIC mutant P254G showed the same non-conductive conformation seen in all other 
structures, a local rearrangement in the α2 - α3 loop has led to an ionic interaction between 
Arg255 of the α2 - α3 loop with a Glu159 of the β8 - β9 loop. I could show that this 
interaction is responsible for the higher stability of the open state. A sequence alignment 
showed that the residues of this salt bridge are not conserved within the family, thus 
suggesting that the observed phenomenon may be unique to the homologue ELIC.  
Most of the structural data obtained for GLIC is in agreement with the proposed opening 
mechanism where the interaction between the backbone of the residue at the tip of the β1 - 
β2 loop to a conserved proline in the α2 - α3 is critical for the stability of the open state (5). 
This interaction during gating will from now on be referred to as ‘tip’ pathway. 
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Figure 51: Schematic representation of a proposed opening mechanism. The conserved proline residue of the α2 - 
α3 pore loop is pushed and hold in an open position by the tip of the extracellular β1 - β2 loop (Adapted from (5)). 
 
The mutation of this rigid proline residue to the most flexible amino acid glycine leads to 
a loss of this contact and therefore a collapsed pore. In the two published ‘loss of function’ 
mutant structures, the α2 - α3 loop adopts a different conformation, which leads to a loss 
of contact between these two loops and to a similar pore conformation. Nevertheless the 
functional phenotype of P250G is not in full agreement with this mechanism, as the mutant 
is still able to activate. 
Similarly, the removal of the backbone interaction partner by shortening of the β1 - β2 loop 
through deletion of a lysine residue (woK32), shows a dramatic reduction of channel 
activity, but not a complete loss of function. The same effect was seen in ELIC, where 
despite the deletion of the equivalent residue Leu29 (woL29) the channel is still activated 
by its ligand, although with a reduced activity. Both tip deletion mutants did still respond 
to their ligand with reduced maximal activity, which indicates that the signal transduction 
for gating is perturbed, but not completely interrupted. 
My results thus exclude the ‘tip’ pathway as the main determinant for gating. 
 
This conserved proline in the α2 - α3 loop has previously been investigated in the nAChR, 
but due to the absence of detailed structural information a potential interaction with the β1 
- β2 loop was not detected. Therefore a different hypothesis has been proposed for the 
importance of this conserved residue. In nAChR (Auerbach and colleagues ((47))) and in 
5-HT3 receptors (Lummis and colleagues ((82))) it was suggested that the proline 
undergoes a cis–trans isomerization during activation. The mutation to alanine would thus 
allow the loop to affect the equilibrium of the isomerization which is reflected and in a 
lower agonist concentration required for activation. A similar effect in the EC50 was seen 
for the equivalent mutation in in GLIC, but not in ELIC where the EC50 of the mutant does 
not change significantly in comparison to WT.  
Auerbach proposes that in the nAChR the conformational changes in the extracellular 
domain following ligand binding (a process called C - capping) is perturbing the potential 
salt bridge between the Arg of the β10 - α1 linker and the Glu of the β1 - β2 loop (Asp31 
in GLIC and Thr28 in ELIC), which was previously assigned to be part of the ‘principal 
pathway of gating’ by Sine and colleagues (45). It could be shown that for the nAChR the 
exchange to various combinations of residues (i.e. A/L, H/A, N/L, K/L, H/R, A/R, N/R and 
Q/R) did still lead to channel activation. Therefore the salt bridge, even though present in 
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the structures of the nAChR (42) and GLIC (33, 50), is likely not one of the main 
determinants for gating (47). This conclusion cannot be extended to GLIC, where the 
disruption of this ionic interaction does not show any channel activation. This indicates that 
for GLIC this interaction is necessary for pore opening. The behavior of ELIC is less 
pronounced than in GLIC and somewhat resembles the nAChR. In ELIC the residue present 
in the β1 of WT is a Thr, whose mutation to Asp strongly enhances channel activation, 
whereas the mutation to Ala results in a weaker, but still ligand-dependent activity. These 
findings are in agreement with the previous findings in nAChR (47), showing that this 
interaction, although important, is not essential for activation. At this point it could be 
speculated that the D31A mutation in GLIC might also still be activated but at a much lower 
pH which is not accessible in a cellular system. Since the mutations in ELIC would indicate 
a much more dramatic effect.  
 
In summary, in my experiments I could show that there is not only one key interaction that 
is important for gating, but it is instead a network of several different pathways which, 
when acting in concert, trigger the opening of the pore. The various pathways include the 
‘tip’ pathway, the hydrophobic network of the ‘cys-loop’ pathway and the ‘principal 
pathway of gating’, which all have also been shown to be important in the mammalian 
nAChR. It thus appears likely that, despite some protein specific differences, the overall 
mechanism of activation is very well conserved within the family. Lessons learned from 
prokaryotic pLGICs are thus relevant for the entire family. 
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4 Outlook 
Although, with recent data on prokaryotic pLGICs, our understanding of channel function 
has increased until now there are no high resolution crystal structures of a single pLGIC in 
different functional states available. Knowledge of such structures will be a prerequisite for 
the comprehension of the gating mechanism. . Therefore an important future task will be 
to get more information and if possible structures of different states of the protein. The 
newly discovered positive allosteric modulators for ELIC are an interesting tool for such 
experiments and should be considered further in combination with the information obtained 
from mutagenesis studies to stabilize and crystallize an open conformation of ELIC. The 
experiments addressing the gating mechanism have so far revealed few very interesting 
mutants, whose functional properties were only superficially characterized by 2EVC. 
Macroscopic and single-channel patch–clamp experiments would extend the study and 
reveal the underlying change in the kinetics and single channel behavior of the mutant. 
These additional data could provide deeper insight into the gating mechanism. 
 Another major task will be a detailed analysis of the conformational properties of the 
protein in detergent solution and the comparison of channels embedded in a lipid 
environment by Electron Microscopy and EPR spectroscopy to obtain insight into the entire 
ensemble of conformations of the protein in their native environment.  
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5 Methods 
5.1 Cloning 
All vectors used in this thesis (Figure 52) were modified by Dr. I Zimmermann to be 
compatible with the FX cloning system. 
 
 
Figure 52: FX-compatible vectors used in this thesis. Both vectors (left and right) contain a SapI cleavable ccdB 
site. This site is important for FX cloning, since this gen is lethal to E. coli MC1061 used for cloning. (left) 
Expression vector in E. coli. This vector fuses the pLGICs with a cleavable N-terminal signal sequence (pelB), a 
deca histidine tag and a MBP fusion protein. (right) Vector used for expression in Xenopus laevis oocytes. This 
vector contains the SP6 RNA polymerase promoter and adds a N-terminal chicken α7 signal sequence to the 
protein.  
The PCR technique was used to amplify genes for FX cloning. FX primers were designed 
to introduce SapI restriction sites on either side of the gene. The primers were generated 
using an algorithm on the online FX platform (www.fxcloning.org) and obtained from 
Microsynth (www.microsynth.ch). The respective genes were amplified with a standard 
PCR protocol using Phusion Polymerase (NEB). The amplified DNA was applied on a 1% 
agarose gel and separated by electrophoresis. The band corresponding to the amplified gene 
was isolated from the gel and purified with the High Pure PCR Product Purification Kit 
(Roche). 
6 µl of the purified gene containing SapI sites were mixed with 1 µl of the desired FX-
compatible vector, 1 µl of SapI restriction enzyme, 1 µl of T4 DNA ligase, 1 µl ATP (10 
mM) and 1 µl 10X Ligase buffer. The mixture was incubated for 1.5 h at 37 ºC and 
inactivated for 20 min at 65 ºC. Following a transformation into E. coli, the cells were 
applied on LB-agar plates containing an antibiotic for selection (Ampicillin –pTLNA7; 
Kanamycin pet26) and incubated ON at 37 ºC. To confirm the sequence of the incorporated 
gene the constructs were sequenced (www.microsynth.ch). After successful FX-cloning of 
the pLGICs the vectors were named pet26 and pTLNA7, not to confuse with the pet26FX 
and pTLNA7FX, which still included the suicide cassette (ccdB). 
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Mutations were inserted with the QuikChange®Site-Directed Mutagenesis protocol 
(Stratagene). Primers were designed using the PrimerX online platform 
(http://www.bioinformatics.org/primerx/cgi-bin/DNA_1.cgi) to insert the desired 
mutations into the gene. Then the primers (Microsynth) were added at a concentration of 
0.25 µM to the QuickChange mixture containing 5 μl of 10× reaction buffer, 1 μl (5–50ng) 
of dsDNA template, 1 μl of dNTP mix (10 mM each), 31.5 μl ddH2O and 1 μl of PfuTurbo 
DNA polymerase (2.5 U/μl). 
5.2 Electrophysiology 
5.2.1 Expression in Xenopus oocytes 
For expression in Xenopus laevis oocytes, constructs of ELIC and GLIC in the pTLNA7 
vector were used (Figure 52). After linearization of the plasmid DNA by MluI, capped 
complementary RNA (cRNA) was transcribed with the Message Machine kit (Ambion) 
using the SP6 RNA polymerase and purified with the RNeasy kit (Qiagen). Depending on 
the expression level of the respective mutant, 50 nl of RNA at a concentration ranging 
between 10 and 400 ng/µl was injected into defolliculated oocytes. For expression oocytes 
were incubated in barth solution (88 mM NaCl, 1 mM KCl, 1 mM CaCl2, 0.33 mM 
Ca(NO3)2, 0.82 mM MgSO4, 10 mM Na-Hepes (pH 7.4) and 50 µg / ml Gentamycin) at 16 
ºC.  
5.2.1.1 Two electrode voltage-clamp recording 
Measurements were performed 1–3 days after injection at 20 °C with the two-electrode 
voltage-clamp technique with an OC-725B amplifier (Warner Instrument Corp). Currents 
for GLIC were recorded in bath solutions containing 130 mM NaCl, 2 mM KCl, 1.8 mM 
CaCl2, 5 mM MgCl2. The respective pH values were stabilized by addition of 10 mM 
HEPES (pH 7.0) or 10 mM of citrate (pH 3.5–pH 5.0). For ELIC the bath solution had to 
be adapted and contained the following: 130 mM NaCl, 2 mM KCl, 0.5 mM CaCl2 and 10 
mM Hepes (pH 7.0). For activation of ELIC the bath solution was supplemented with 
agonist (propylamine or cysteaime) at concentrations varying from 1 µM up to 50 mM 
depending on the mutant. For the characterization of channel block of GLIC the bath 
solution was supplemented with the specified inhibitor concentrations. For recording in 
solutions containing either Zn2+ or Cd2+, citrate was replaced by 10 mM glucuronate. 
Electrodes were bathed in 1 M KCl solution connected to the bath solution by agar bridges. 
5.2.1.2 Oocyte surface expression assay 
Xenopus oocytes were injected and maintained as described above. The amount of cRNA 
had to be adapted for each mutant and varied from 5 ng/µl for ELIC WT to 450 ng/µl for 
certain mutants. Surface assays were performed 2–4 days after injection. For surface 
labeling, oocytes were blocked for 30 min in ND96 (93.5 mM NaCl, 2 mM KCl, 1.8 mM 
CaCl2, 2 mM MgCl2 and 10 mM Hepes (pH 7.4)) with 1% bovine serum albumin (BSA) at 
4°C, labeled with 1 µg/ml rat monoclonal anti-HA antibody (3F10 (Roche), in 1% BSA for 
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90 - 120 min at 4°C), washed 4x 10 min at 4 °C, and incubated with 0.16 µg/ml horseradish 
peroxidase–(HRP) coupled secondary antibody (HRP-conjugated goat anti-rat F(Ab)2 
fragments (Jackson), in 1% BSA for 30–60 min at 4°C). Cells were extensively washed 
(1% BSA, 5x10 min, 4 °C) and transferred to ND96 solution without BSA. Individual 
oocytes were placed in 50 µl Power Signal ELISA (Pierce) and incubated at room 
temperature for 1 min. Chemiluminescence was quantitated using Perkin 96 Flat Bottom 
white polystyrol plate with a Tecan infinite M-10000 plate reader. 
5.2.1.3 Assay to quantify the maximal evoked currents per surface expressed channels 
Xenopus oocytes expressing the respective channels were prepared as described above. The 
amount of cRNA was chosen based on the results of the surface expression assays and 
varied from 5 ng/µl to 450 ng/µl. Two-electrode voltage-clamp measurements were 
recorded 2-3 days after injection at 20 °C (OC-725B, Warner Instrument Corp.) as 
described above. Required agonist concentrations for the recording of maximally evoked 
currents was obtained from previous dose-repose measurements of each mutant. After the 
measurement of the maximal currents the oocyte was washed in bath solution (and collected 
in a 96 well plate). As a control uninjected oocytes and oocytes injected with WT RNA 
were treated with the same protocol. After recording surface expression was assayed as 
described (5.2.1.2). 
5.3 Biochemical and structural methods 
5.3.1 Small scale stability screening of mutants 
The stability of mutants of ELIC and GLIC that were targeted for structure determination 
was initially investigated in small-scale expression cultures. pet26 vectors containing the 
respective constructs were transformed into BL21(DE3) cells and grown in terrific broth 
(TB) medium (12 g peptone, 24 g tryptone, 4 ml glycerol, 50 mg kanamycin, 2.31 g 
KH2PO4 and 12.54 g K2HPO4 per liter). For small scale experiments, the cells were grown 
in 5 mL TB at 37ºC to an OD600 between1.6 and 1.8 and subsequently cooled to 19 °C. 
Protein expression was induced with 0.2 mM IPTG for 12–13 hours at 19 °C. The overnight 
cultures were collected and resuspended in purification buffer A (50 mM K2PO4 pH 8.0, 
150 mM NaCl) with addition of 1 mM phenylmethyl sulfonyl fluoride (PMSF), 20 mg/ml 
DNaseI, 1 mg/ml lysozyme, 1 mg/ml pepstatin and 1 mg/ml leupeptin. The cells were lysed 
on a FastPrep-24, solubilised for 1 h in 0.9 mM DDM, centrifuged at 10’500 g for 15 min 
to remove the cells debris and incubated for 30min with 1 ml Ni-NTA beads. The Ni-NTA 
resin was subsequently loaded on a gravity flow column and the eluate was monitored by 
recording of the AU280. Beads were washed with buffer A containing 15 mM and 55 mM 
imidazole until baseline was reached. The protein was subsequently eluted with buffer A 
containing 300 mM imidazole in a final volume of ~25 ml. To remove the His10-tag and 
the MBP, the eluted fusion protein was digested for 2 h at 4 °C by addition of 3C precision 
protease in a 1:20 w/w ratio of protease to fusion protein. During the 2 h incubation the 
solution was dialyzed against a buffer containing 10 mM K-Phosphate (pH 8.0), 150 mM 
NaCl and detergent at a concentration of 1.2 CMC to remove the imidazole. After cutting, 
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the solution was passed over the same Ni-NTA column used for purification to remove the 
MBP/His10-tag and the His-tagged 3C protease. After the elution of the 2
nd Ni-NTA column 
the samples were centrifuged for 10min at 100’000g (Beckman). 70 µl of each sample was 
transferred on a NUNC 96-well plate and subjected to FSEC. For that purpose50 µl aliquots 
were applied to a TOSOH BIOSCIENCE G3000SWXL gel-filtration column, mounted on 
an Agilent HPLC. Samples were eluted at 1 ml/min, in buffer A and the Trp-fluorescence 
was recorded on a fluorescence detector with an excitation wavelength of 280 nm and an 
emission of 320 nm). For analysis the respective peak heights and elution volumes of the 
mutants were compared to WT. 
5.3.2 Large scale Expression and membrane purification 
Constructs of GLIC and ELIC were expressed in E. coli as a fusion to the C terminus of 
maltose binding protein (MBP) that was preceded by an E. coli pelB signal sequence and a 
decahistidine (His10) tag. For this purpose the constructs were cloned into the pet26FX 
vector using the FX-cloning method. The plasmids were transformed into BL21 (DE3) cells 
and grown in terrific broth (TB) medium. For ELIC 16 0.6 l shaker flasks, and for GLIC 
32 0.6l flasks were used. Cells were grown at 37 ºC to an OD600 of 1.6 to 1.8 and 
subsequently cooled to 19 °C. Protein expression was induced with 0.2 mM IPTG for and 
proceeded for 12–13 hours at 19 °C. 
Cells were harvested by centrifugation for 10 min at 5.000 rpm with a Sorvall SLC-6000 
rotor. The cell pellet was subsequently resuspended in 50 mM K-Phosphate (pH 8.0), 150 
mM NaCl (buffer A) with the addition of 1 mM phenylmethyl sulfonyl fluoride (PMSF), 
20 mg/ml DNaseI, 1 mg/ml lysozyme, 1 mg/ml pepstatin and 1 mg/ml leupeptin. Cells were 
lysed with an Emulsiflex high-pressure homogenizer (Avestin) with three to four passages 
at ~6000 psi and the lysate was cleared by low-spin centrifugation at 10.500 g for 15 min. 
Membranes were isolated by ultracentrifugation for 1 h at 45.000 rpm on aTI-70 rotor 
(Beckmann). For storage membranes were homogenized in 10% sucrose (w/v) in 1 / 10 of 
the final extraction volume, flash-frozen in liquid nitrogen and stored at -80 °C. 
5.3.3 Protein preparation 
The frozen membranes were homogenized in buffer A (10 ml buffer/g of membrane) and 
extracted by addition of 2 % detergent. For crystallization ELIC was extracted with n-
undecyl-β-D-maltoside (UDM, Anatrace, Inc.) and purified in buffers containing 3 mM 
UDM, whereas GLIC was extracted with n-dodecyl-β-D-maltoside (DDM, Anatrace, Inc.) 
and purified with 0.5 mM DDM in all following buffers. Extraction was carried out for 
1.5h at 4 °C and the solution was subsequently centrifuged for 20 min at 17.000 rpm on a 
Heraeus 3335 rotor. The supernatant was supplemented with 15 mM imidazole to reduce 
unspecific binding to the IMAC column. Both homologues were purified by affinity-
chromatography on Ni-NTA resin (Qiagen). For this purpose the protein was supplemented 
with 12.5 ml Ni-NTA beads and incubated for 40 min. Afterwards the mixture was loaded 
on an empty gravity flow column and washed with buffer A containing 15 mM and 55 mM 
imidazole until OD280 reached baseline. The protein was eluted with buffer containing 300 
mM imidazole in a final volume of ~25 ml. To remove the His10-tag and the MBP, the 
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eluted fusion protein was digested for 2 h at 4°C by addition of 3C precision protease in a 
1:20 w/w ratio of protease to fusion protein. During these 2 h the solution was dialyzed 
against a buffer containing 10 mM K-Phosphate (pH 8.0), 150 mM NaCl and detergent at 
a concentration of 1.2 CMC to remove the imidazole. After cutting, the solution was passed 
over the same Ni-NTA column used for purification to remove the MBP/His10-tag and the 
His-tagged 3C protease. The flow-through containing the pLGIC was collected and 
concentrated using a Vivaspin Centrifugal Filter Unit (Millipore) with a 30 kDa molecular 
weight cutoff to a volume of ~ 400 µl. The protein was filtered (Millipore 0.22 µm spin 
filters) and then subjected to gelfiltration on a Superdex S200 column (GE Healthcare) in 
a buffer containing 10 mM Tris (pH 8.0), 150 mM NaCl and either 3 mM UDM (for ELIC) 
or 0.5 mM DDM (for GLIC). The chromatogram usually showed two peaks, one at the void 
volume of the column and a second peak corresponding to a pentameric channel (at 11.2 
ml). The second peak was pooled and used for further experiments. 
5.3.4 Crystallization and crystal preparation 
GLIC and ELIC were crystallized in sitting drops at 4 °C. Crystals were obtained by mixing 
protein containing additional 0.5 mg / ml E. coli polar lipids (Avanti Polar Lipids, Inc.) in 
a 1:1 ratio with reservoir solution containing between 200-500 mM (NH4)2SO4, 50 mM 
sodium acetate (pH 4.0), 9–13% (w/v) PEG 4000 for GLIC and 200–300 mM (NH4)2SO4, 
50 mM ADA (pH 6.5), 9–14% (w/v) PEG 4000 for ELIC. For cryoprotection, the crystals 
were transferred into mother liquor containing 30% (v/v) ethylene glycol and flash-frozen 
in liquid propane. For structural studies on channel block in GLIC, the complexes were 
obtained either by cocrystallization or by soaking of native crystals in solutions containing 
the respective inhibitors (5 mM TBSb (Aldrich), 10 mM TEAs, 30 mM TMAs, 15 mM 
bromo-lidocaine). For divalent ions, NaCl was replaced by the respective Cl− salt (100 mM 
ZnCl2 or 50 mM CdCl2).  
5.3.5 Data collection and refinement 
All datasets of ELIC and GLIC were collected on frozen crystals on the X06SA beamline 
at the Swiss Light Source of the Paul Scherrer Institute on a 6M PILATUS detector 
(Dectris). For block studies a suitable wavelength to maximize the anomalous diffraction 
of the bound inhibitors was chosen (As, 1.04 Å; Br-: 0.92 Å; Cd2+: 0.46 Å; Sb+: 0.4 Å; Zn2+: 
1.28 Å). The data were indexed, integrated and scaled with XDS (83) and further processed 
with CCP4 programs (84). The crystals for all mutants and complexes were isomorphous 
to WT (GLIC space group C2 (cell dimensions: a = 178.5 Å, b = 133.5 Å, c = 160.5 Å, α 
= γ = 90°, β = 106.1°) and ELIC P21 (cell dimensions a = 105.5 Å, b = 266.2, Å, c = 110.85 
Å, α = 90.0°, γ = 90.0°, β = 109.5°)). The structures of GLIC (PDB code 3EHZ) and ELIC 
(PDB code 2VLO) without water molecules served as starting models that were improved 
by rigid-body refinement in PHENIX (85). The electron density was inspected and 
structural changes, mutations and heavy atoms were introduced in COOT (86) and 
subsequently refined in PHENIX. For datasets exceeding a resolution of 3.6 Å, the 
structures were additionally subjected to refinement of individual atom positions in 
PHENIX maintaining global NCS constraints. In later stages, the strict constraints were 
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loosened (to account for subtle differences between each subunit) and restraint individual 
B-factors were refined. Rwork and Rfree were monitored throughout. Rfree was calculated 
from the same 5% set of reflections that were initially selected and omitted in the 
refinement.  
For the calculation of the anomalous difference densities, a high resolution cutoff of I/σI > 
5 was used throughout. The one-dimensional density profile along the pore was sampled 
using the program MAPMAN (84). The molecular surface was calculated with MSMS (87). 
5.3.6 Isothermal Titration Calorimetry 
The proteins (ELIC WT and its mutants) were purified as described above except that the 
gelfiltration buffer was exchange for the ITC buffer (25 mM Hepes pH 7.0, 150 mM NaCl, 
and 0.9 mM UDM). The purified protein was dialyzed overnight at a concentration between 
100-250 µM (monomer) against ITC Buffer. Binding of the agonist propylamine and the 
antagonist acetylcholine to ELIC was measured by isothermal titration calorimetry (ITC) 
with a MicroCal ITC200 system (GE Healthcare). The syringe was loaded with agonist 
solution containing a 300x molar excess of propylamine or acetylcholine to the monomer 
dissolved in ITC buffer for ELIC WT, a 175x excess for the mutant R91A and a 70x excess 
for the ELIC mutant T28D.The sample cell was loaded with 300 µl of purified ELIC in ITC 
buffer. Ligand was applied by sequential injections of 2 µl aliquots followed by a 180-240 
s equilibration period after each injection. A heat of dilution recorded by injection of the 
ligand into ITC buffer not containing any protein was subtracted from the measurement. 
The background corrected data was analyzed by a fit to a single-site binding isotherm 
(Origin 7.0). 
5.3.7 EPR 
5.3.7.1 Sample preparation 
The mutants of ELIC and GLIC were essentially purified as described before with the 
following deviation: after the elution from the 2nd Ni-NTA column the protein 
concentration was measured and a 1:1.5 molar ratio of MTSSL label was added. The protein 
was subsequently incubated with the label for 3hs or o/n. To get rid of the excessive spin 
label the mixture was subjected to gel-filtration (in the same buffer as described before). 
The protein peak corresponding to the pentamer was pooled and concentrated to 10-15 
mg/ml. For each construct two aliquots of 50 µl each were used for the EPR experiment. 
One aliquot was recorded under ligand-free conditions, the second aliquot was mixed with 
agonist (10 mM propylamine for ELIC and 50 mM Acetate (pH4) for GLIC). For cryo-
protection 10% D-glycerol was added as a last step to each sample, before flash freezing it 
in liquid nitrogen. 
5.3.7.2 Continuous Wave (CW) EPR Measurements 
EPR spectra were recorded at X-band frequencies (9.3–9.4 GHz) with a Bruker Elexsys 
580 spectrometer equipped with a Bruker super-highQ cavity and a continuous flow N2 
cryostat. For room temperature recordings, the microwave power was set to 0.6 milliwatts 
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and the B-field modulation amplitude to 0.1 milli-Tesla. To quantify the labeling efficiency 
the CW spectra of the sample was compared to a standard (100 µM TEMPOL) measured 
afterwards on the same spectrometer, which allowed the quantification of the label 
concentration in the sample and the ratio of label to protein subunit. 
5.3.7.3 DEER EPR Measurements and Data Analysis 
Q-band DEER measurements with high power excitation were performed using the 
homebuilt Q-band spectrometer operated from a standard console (Bruker) equipped with 
a pulsed TWT amplifier with a nominal output power of 150 W (Applied Systems 
Engineering Inc.). All measurements were performed using the four-pulse DEER 
experiment. Experimental data were collected at 50 K with observer pulse lengths of 16 ns 
for π/2 and 32 ns for π pulses, with the electron double resonance π pulse set to 12 ns. 
Proton or deuterium modulations were averaged. Data analysis of the DEER traces was 
performed with the software DeerAnalysis 2008.1. 
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6 Appendix A 
6.1 Abbreviations 
2EVC Two electrode voltage clamp 
5HT 5-hydroxytryptamine, or serotonin 
Ach acetylcholine 
AChBP Acetylcholine Binding protein 
Ala Alanine 
Asp Aspartate 
Cys Cysteine 
EC50 Conc. of agonist that leads to 50% of the maximally evoked 
currents 
EPR Electron Paramagnetic Resonance 
ELIC Erwinia chrysanthemi Ligand-Gated Ion Channel 
GABA γ-amino butyric acid 
GLIC Gloeobacter violaceus Ligand-Gated Ion Channel 
Gly Glycine 
Glu Glutamate 
IC50  Conc. of inhibitor that leads to 50% of the maximally evoked 
current 
ITC Isothermal Titration Calorimetry 
Leu Leucin 
LGIC Ligand-Gated Ion Channel 
nAChR nicotinic acetylcholine recpeptor 
pa propylamine 
pLGIC pentameric Ligand-Gated Ion Channel 
SCAM substituted cysteine accessibility method 
Tyr Tytosine 
Val Valine 
WT wild type 
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7 Appendix B 
7.1 Structural characterization of prokaryotic pLGICs by double echo 
electron spin resonance (DEER) spectroscopy. 
In collaboration with Dr. Polyhach Yevhen (yevhen.polyhach@phys.chem.ethz.ch).  
 
7.1.1 Aim 
 
In the course of the studies on signal transduction across the domain interface of ELIC and 
GLIC I have crystalized several mutants of the two prokaryotic homologues. Despite the 
pronounced phenotypes observed in electrophysiological experiments, the structures of the 
mutants generally showed, apart from local changes, similar conformations. These 
observations suggested that only a subset of possible conformations of the channels may 
be accessible in detergent solution. In the membrane protein field the question in how far 
detergent solubilized proteins reflect the natural behavior of the protein in a lipid 
environment is a topic of continuous debate (88-91). 
In this work, I have attempted to characterize the different conformations of the pore region 
that are accessible in detergent solution and try to relate them to the conformations seen in 
the know crystal structures. For that purpose I have used DEER measurements, an EPR 
method which measures distances between introduced spin labels, to determine 
conformational changes in the transmembrane domain induced by the binding of the ligand. 
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7.1.2 Results 
In order to determine whether the two prokaryotic homologues ELIC and GLIC undergo 
structural rearrangements in a detergent environment, I performed “double echo electron 
spin resonance” (DEER) EPR experiments. In such experiments, a methanethiosulfonate spin 
label (MTSSL, (92)) is introduced to the protein. This MTSSL reagent is a highly reactive, 
thiol-specific label and contains a group with a stable free radical (unpaired valence 
electron) that can be detected by EPR. The DEER experiment measures the distance 
between the free radicals, which are covalently linked to the protein via accessible cysteines 
(Cys).  
 Initially, a cys-free version of the protein was constructed. For that purpose both natural 
Cys residues present in either protein were mutated to valine or leucin by site-directed 
mutagenesis. To confirm that these cys-free mutants of ELIC and GLIC are still 
functioning, they were analyzed in two electrode voltage clamp (2EVC) experiments (40, 
58). For that purpose Xenopus oocytes were injected with cRNA coding for the different 
mutants. After a few days ligand-induced currents were measured at a holding potential of 
-50 mV. These experiments showed that the cys-free mutants still respond to the ligand in 
a similar manner as WT (Data not shown). 
 The next step was to introduce single cys residues by site-directed mutagenesis. For an 
accurate measurement of an introduced spin label in an EPR system several factors had to 
be considered. First, the sites need to be accessible for labeling and second, the distance 
between each spin label should be in a detectable range between 1.5–8 nm. To accurately 
distinguish conformational changes, distances have to differ by at least 0.15 nm (93). 
The proposed opening mechanism based on the two available structures was taken as a 
starting point to select appropriate positions (5). In this mechanism the extracellular and 
the pore domain undergo two distinct conformational changes upon channel activation.  
One is a rotation for each extracellular subunit around an axis that is slightly tilted with 
respect to the channel axis, whereas in the pore domain a rotation is assumed for each 
subunit around an axis that is perpendicular to the pore. With regards to the transmembrane 
domain, these changes should only affect helices α2 and α3, whereas the other two α-helices 
(1 and 4) remain largely unchanged. Based on this model, the structural differences 
assumed for the pore domain would be in the suitable range for EPR distance measurements 
(Figure 53). Helix α3 was chosen for labeling due to its better accessibility and since the 
label distances are in the appropriate range for EPR experiments. 
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Figure 53: (top) Ribbon representation of the crystal structures of GLIC (left) and ELIC (right). The front subunit 
has been removed for clarity. Red lines in both structures in the pore domain show the expected movement of 
helixα-3 upon pore opening. For GLIC these helices are arranged in a funnel-shaped manner, whereas for ELIC 
they are cylindrical. (bottom) Extracellular view on the TM part of both homologues (GLIC, left, ELIC, right). 
The dimension of the pentagon differs significantly between the two homologues. In GLIC the α3 helices on the 
extracellular side are further apart from each other than in ELIC. 
 
To identify appropriate labeling positions in the pore domain, simulations were performed. 
These simulations take into account the accessibility and flexibility of the spin-label 
attached to the structure of the protein at a certain position (by using a rotamer library within 
the MMM program (94)). The structure itself was assumed to be immobile in these 
simulations. An example for such a simulation on GLIC is shown in Figure 54. The 
simulation of the DEER experiment shows an appropriate distance distribution (bottom 
right - red) for this site in GLIC that is in a sensible range for DEER experiments. Two 
distinct sharp distance peaks are observed, one of which had a small shoulder at a short 
distance range (Figure 54). 
These two peaks are due to the fact that there are two possible monomer distances observed 
within the pentamer, a short distance between two adjacent subunits and a long distance 
between subunits in 1 - 3 position. 
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Figure 54: (top) MMM simulation of the accessible rotamers of the spin labelled GLIC mutant L278C. GLIC is 
shown in ribbon representation (grey). The MTSSL attached to the protein is in yellow. The possible spin location 
is shown as red spheres. (bottom, left) Background corrected dipolar evolution function (Form factor, F (t) -
simulated DEER traces) based on the distance distributions (P (r)) of the rotamer cloud in red. (bottom, right) 
Corresponding distance distribution P(r) of the DEER trace is shown in red. 
To address the question whether the structural rearrangements are as proposed by the 
model, two positions (on the intra- and extracellular part of α-helix 3) were selected for 
each homologue. The intracellular position was located at the extracellular start α-helix 3 
(i.e. at Phe281 in ELIC and Ala278 in GLIC). The simulated traces and the corresponding 
distance distributions for this position look significantly different to be distinguishable 
(Figure 55). In GLIC, the short distance shown in the simulation has its peak height at 
around 2.8 nm, whereas the long distance would be around 4.6 nm. While in ELIC the 
corresponding sites would be at a short distance of 3.3 nm and a long distance of 5.2 nm. 
The distance differences between these two simulations, of 0.5 nm for the short and 0.8 nm 
for the long distance, would also be in the detectable range for a DEER experiment. 
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Figure 55: Results of a simulated DEER experiment at the Position ELIC F281C and GLIC L278C based on their 
respective crystal structure. (left) Simulated DEER signal. The signals show already at short time ranges 
significant differences. (right) Corresponding distance distribution of the DEER simulation.  
On the extracellular side of the pore, residues at the N-terminal end of α helix 3 were 
selected (i.e. Gly263 for ELIC and Ala256 for GLIC). The distance distribution for the 
ELIC mutant G263C (red) is broad, indicating a bigger flexibility for the spin label (Figure 
56). The short distance has several peaks that are spread between 2.5 nm up to 3.8 nm. The 
long coupling distances is reflected in a peak around 4.9 nm. For the equivalent position in 
GLIC (i.e. A256C) the distance distribution is sharper. Two peaks for the short distance 
(around 3 nm and 3.6 nm) and one peak (5.2 nm) for the long distance are clearly 
distinguishable. 
 
 
Figure 56: Results of a simulated DEER experiment for the mutants ELIC G263C (red) and GLIC A256C (blue) 
based on their crystal structure. (left) Simulated DEER signal. The signals show already significant differences at 
early time points. (right) Corresponding distance distribution of the DEER simulation. . 
To exclude that the introduction of the amino acid cysteine would affect the ability of the 
channel to open, 2EVC experiments were performed. These experiments showed that the 
introduced Cys did not change the functional properties of the channel (Figure 57).  
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Figure 57: Does response 2EVC traces of the Cysteine mutants in A256C and L278C of GLIC (left) and F281C 
and G263C of ELIC (right). pH values (for GLIC) concentration of the ligand propylamine (for ELIC) are 
indicated. The voltage was set to -70 mV. 
For the EPR experiments the mutated channels had to be purified in large amounts and 
subsequently labeled. To investigate whether the introduction of a cysteine might have 
altered the properties of the different mutants in E. coli, their expression was studied in 
small scale cultures. These experiments showed that for mutants in the extracellular part of 
the pore the ELIC mutant F281C was stronger expressed than the corresponding mutant 
L278C in GLIC. An opposite behavior was found for the mutations at the intracellular part, 
where A256C of GLIC expressed at higher yields than G261C of ELIC (Figure 58). 
 
 
Figure 58: Western Blot analysis of the expression properties of different Cys mutants of ELIC and GLIC 
expressed in E. coli BL21 cells. The His-tagged proteins were detected with an Anti-His Antibody. 
 
For labeling the proteins were expressed in a 9.6 l for ELIC and 19.2 l for GLIC, purified 
in the detergent DDM and incubated with the spin label. To confirm that the sites are 
accessible to the spin label (MTSSL) and to quantify the labeling efficiency, a continuous 
wave (CW) experiment was performed. These experiments showed a complete 
incorporation of MTSSL at the free cysteines (data not shown) and thus confirmed that the 
site is accessible. At this point the labeling strategy had to be optimized. This optimization 
was needed, since a pentamer, if all sites are labeled, would contain five spin labels. In a 
system, which has more than two direct spin neighbors multi spin interferences may 
complicate the analysis. In this case each spin is influenced by the decay and interferences 
of differently behaving spins which results in a complex pattern that is difficult to 
deconvolute. To overcome this problem, a molar ratio of pentamer to spin label of 1:1.5 
was used for labeling. In such a case, on average one pair of labels would be introduced 
- 89 - 
and thus only a single distance per pentamer would be measured, without mutli spin 
interference. After CW experiments have confirmed the expected ratio of label to protein, 
DEER data was recorded to obtain distance distributions. Initial DEER experiments with 
the labeled mutant F281C-MTSSL of ELIC showed a very fast relaxation time (Tm), which 
does not permit accurate distance measurements (Figure 59).  
 
 
Figure 59: DEER spectrum of the ELIC F281C labeled mutant. The sample is very noisy and that there are no 
oscillations are visible. 
 
To decrease the spin relaxation, 10 % of deuterated D-glycerol had to be added. Glycerol 
acts as cryoprotectant and prevents the formation of water crystals upon flash-freezing in 
liquid nitrogen, which could denature the protein sample. The deuterated form of glycerol 
is used for technical reasons: Protons (H) have a nuclear spin, which is detectable in NMR 
experiments. In the DEER experiment, all free valance electrons (radicals) are aligned in 
the field – which results in a signal whose decay is recorded in the measurement. Electron 
spins and nuclear spins are excited at different wavelengths, therefore in a DEER 
experiment the nuclear spins are not excited. However, each spin creates a local magnetic 
field, which is sensed by all other spins, regardless of their origin. This magnetic field leads 
to a disturbance of the align spins of the DEER experiment and therefore to a faster decay 
of the signal. By adding a deuterated compound into the solution the number of nuclear 
spins in the system, and thus the interference is reduced. The addition of D-glycerol allowed 
the recording of the signal up to 4 µs, which made it possible to measure distances to 
maximally 4.5 nm. For accurate distances measurement of additional distances, a longer 
time span would have to be measured. Therefore in this study, only the short distances of 
the system were taken into consideration. After optimization of the labeling and the 
reduction of the noise and the spin relaxation time a DEER spectrum was recorded. For that 
purpose each cys mutant was purified, labeled, cryo-protected and flash-frozen. For the 
label at the intracellular side of the pore in ELIC (mutant F281C) the data was of sufficient 
quality to allow the quantification of the shorter of the two possible distances. The 
measurement of the protein in the absence of its agonist showed 2 peaks (Figure 60), a big 
and broad peak for the short distance at a maximum at around 2.9 nm and a smaller peak 
for the long distance at around 5.8 nm. Similarly two peaks were observed in the presence 
of the agonist, with one having a maximum at around 3.2 nm and another around 5 nm. 
Despite the recorded difference in the short distance upon application of the agonist, this 
difference could also arise from the different phase drifts and noise during the experiment. 
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Therefore more measurements need to be performed to accurately quantify potential 
conformational changes upon ligand application. 
 
 
Figure 60: DEER traces of the labeled ELIC mutant F281C. (left) DEER signal (form factors) in the presence 
(blue) and absence (black) of the ligand. (right) Corresponding distance distribution in the same coloring scheme. 
From the comparison of the DEER signal it is hard to judge whether the obtained changes in the distance 
distribution reflect a conformation change or whether they originate from noise. 
 
Analogous experiments were performed for the position A256C at the extracellular part of 
the pore of GLIC. After optimization of the labeling procedures (CW data not shown), a 
DEER experiment was recorded. Also, for this mutant of the pH gated channel GLIC, the 
protein was incubated at two distinct conditions, at high (pH 4) and low proton 
concentration (pH7). In both cases, a DEER signal could be measured which only allowed 
the accurate determination of the short distance. The sample that was incubated at neutral 
pH (Figure 60, blue trace) had two distinct peaks. The short distance had its maximum at 
around 3.4 nm while the long distance is around 5.5 nm. For the samples that were 
incubated at low pH the recording showed, despite the high concentration of the ligand 
which should favor the open state, a very similar pattern to the one observed at neutral pH. 
The long distances overlapped and in the region of short distances, three overlapping peaks 
were formed (with maxima at 2.9 nm, 3.8 nm and 4.2 nm). Due to the weak signal, however, 
the values have to be taken with caution as it is still possible that all three peaks correspond 
to one distance around 3.3 nm (Figure 61). 
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Figure 61: Superposition of the DEER data of the labeled GLIC mutant A256C recorded at pH4 (black) and ph7 
(blue) (left) and the corresponding distance distribution (right) The red line on the left panel shows the fit to the 
data recorded at pH 4..  
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7.1.3 Discussion 
In this study DEER experiments were used to characterize ligand-induced conformational 
changes in the two prokaryotic homologues ELIC and GLIC and to assess whether such 
changes could be observed for the detergent solubilized protein. Currently it is not known 
whether the structural rearrangements underlying pore opening in a lipid environment are 
also accessible in detergent solution.  
For the intracellular part of the transmembrane domain, the ELIC mutant F281C was 
selected. In the absence of the ligand, the measured signal does not correspond very well 
to the simulated MMM signal of the spin label added to the respective position of the crystal 
structure. Whereas the simulated distance was around 3.4 nm, maximum of the broad peak 
of in the distance distribution measured in the DEER experiment was around 3 nm, which 
indicates that in solution, the actual distance is smaller than in the crystal environment but 
bigger than predicted in the simulations of the equivalent position in GLIC. The observed 
distance distribution thus shows a pore, with dimensions in-between the crystal non-
conductive structure of ELIC and the conductive structure of GLIC. It could thus be that 
the crystal structure shows a conformation that is biased by the crystallization conditions. 
The smaller distance could easily be obtained by a slight tilting of the α2 and α3 helices 
without changing the functional state of the protein. 
Upon ligand activation, the proposed mechanism would predict a narrowing of the pore, to 
reach its funnel-like shape. This reduced distance would also be required for the glutamates 
at the end of the α2 helix to form a selectivity filter (5, 49). In my experiments the opposite 
movement, a potential widening of the pore by 0.3 nm, was observed upon ligand addition. 
The correspondence of the distances in the presence of the ligand with the crystal structure 
of ELIC (crystallized in the absence of its ligand), indicates that observed structure may 
resemble a desensitized state, the stable conformation of the channel in the presence of its 
agonist. ITC experiments (67) in contrast do not support the hypothesis of the detergent 
extracted protein resembling a desensitized state. There the measured affinity of the channel 
to its ligand is too weak, since in a desensitized state the binding affinity is expected to be 
much higher (13). The fact that the ligand-bound state in detergent solution can neither be 
assigned to an activated nor a desensitized state indicates that the protein in detergent 
solution may behave differently than in the membrane. 
In any case more accurate data is required to reach conclusive results. Such experiments 
may benefit from recent the advances in data acquisition and mutants, which lock the 
protein in specific states and that would thus allow to more accurately determine structural 
differences. For the GLIC mutant A256C labeled in the extracellular part of the pore, the 
experimental and simulated results for the pH 4 condition were very similar. It can thus be 
concluded that the state seen in the crystal structure is also present in solution. At neutral 
pH, where the protein is expected to change into a resting state, the same distance 
distribution was observed. These results indicate that the conformation of the α3 helices 
seen in ELIC are not found for the homologue GLIC, which could either indicate that there 
is no structural rearrangement in this position upon pore opening, as proposed in recent 
studies (5), or that this conformation cannot be reached in detergent solution. A novel 
activation mechanism for GLIC was proposed based on different crystal structures (62, 95, 
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96). In this mechanism, activation underlies a local reorganization of the α2 helix, whereas 
the α3 helix retains its conformation in both states of the protein. The results of this study 
are in agreement with this mechanism. It can, however, also not be excluded that the protein 
in detergent solution may not be able to adopt all conformations accessible in the membrane 
environment. Recent findings from EPR experiments on the homologue GLIC have indeed 
shown a different structural behavior in a detergent and a lipid environment (96).  
 
In the EPR studies on ELIC and GLIC I was able to observed two different behaviors. In 
ELIC, where distance changes in the intracellular part of the pore were studied, I have 
observed, a narrower pore than seen in the crystals structure in the absence of the ligand. 
Upon ligand binding, this pore appears to widen to the dimensions seen in the crystal 
structure, which could indicate that in its pore region the crystal structure could resembles 
a ligand bound, desensitized state. 
With regards to GLIC, my findings are not in agreement with an initial model that have 
proposed a change from an ELIC to a GLIC-like conformation upon ligand activation, but 
they correspond to the newer finding of activation by local changes the α-helix 2. 
These conclusions are very preliminary and still speculative since they all rely on 
measurements of a single position whereas data of more positions would be required to 
obtain conclusive insight. It should also be emphasized that the data quality will have to be 
significantly improved. Finally all experiments should be remeasured after reconstituting 
of the protein into a lipid environment, such as nanodiscs (97) or liposomes. Since 
experiments in detergent solution might not exactly reflect the conformational behavior of 
the protein in its lipid environment (91).  
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8 Appendix B 
8.1 Modulation of the prokaryotic pLGIC ELIC 
8.1.1 Introduction 
8.1.1.1 Partial agonists 
pLGICs can be activated by a variety of different chemical compounds. Some molecules, 
which bind to the same binding site as the agonist, at full occupancy only evoke a fraction 
of the maximum response of the channel. These orthosteric modulators are called partial 
agonists. In the del-Castillo-Katz model this phenomenon is explained by differences in the 
efficacy of gating (8). Based on analysis of single channel events with different 
concentrations of full and partial agonists, a new intermediate was proposed, the flipped 
state. This state was seen to correspond to a conformational rearrangement in the 
extracellular domain, before pore opening, and could correspond to the C–loop capping 
seen in AChBP. Additionally, these experiments revealed that the difference of partial and 
full agonist is not due to the gating step, but rather because of the transition between the 
resting ligand bound state and the flipped state (98). 
 
8.1.1.2 Allosteric modulators 
pLGICs are allosteric proteins, which exist in several different conformational states. The 
distribution between these states is related to their free energy by a Boltzman distribution. 
Allosteric modulators can bind to one or several of these states and such influence their free 
energy, which in turn leads to a different population of states and thus a shift in the 
equilibrium. The binding site of these modulators is not confined to a specific place but can 
instead be in different parts of the protein. Allosteric modulators influence the apparent 
affinity of the receptor to the agonist by influencing the equilibrium between the open and 
closed states once the ligand is bound. This effect can either be positive or negative. 
Positive modulators are termed allosteric potentiators, while negative ones are called 
allosteric inhibitors.  
As described earlier a change in the EC50 does not allow to discriminate whether the effect 
shifts the genuine affinity of the ligand or the efficacy of pore opening. Therefore further 
investigations are required to address whether which parameter would be influenced. 
Different to competitive inhibitors is that the effect is saturable. (18). 
 
Several allosteric modulators of pLGICs have been discovered and characterized. All have 
distinct binding sites in the in the receptor, distant from the agonist binding site. The 
chemical composition of these modulators vary highly from small proteins to ions and for 
the α7 nAChR 
 PAMs have been considered as potential drugs (72). 
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Calcium ions were the first known allosteric potentiatiors of α7 nAChR (99) responses, 
followed by the discovery of the antiparasitic agent ivermectin (100). Unfortunately, these 
“first generation” α7 PAMs lack desirable potency, efficacy, and/or selectivity profiles for 
potential drug targets. For example, ivermectin is non-selective, since it also works on other 
pLGICs (6). 
Since the discovery of the first α7 nAChR modulators, small molecular PAMs with diverse 
potency, efficacy and selectivity profiles have emerged. These discoveries have led to the 
classification of PAMs into two categories. The PAMs classified as type I, increase the 
amplitude and therefore the efficacy of an agonist but they do not alter the kinetics of 
agonist-evoked responses. Type II PAMs appear to slow or reverse α7 nAChR 
desensitization and therefore show higher currents than obtained from agonist application 
alone (Figure 62). 
 
 
Figure 62: Schematic mechanism of activation and desensitization of pLGICs in the absence and presence of 
PAMs. In the first step the receptor binds to its ligand. This step is described by the affinity constant KD. In the 
second step the bound ligand induces a conformational change in both the extracellular and pore domain 
characterized by the efficacy (E). In a third step the activated, ligand bound, channel can go into a desensitized, 
non-conductive, state. The positive allosteric modulators (PAM) bind the channel in the closed, ligand unbound 
state. In the presence of PAMs two effects can be observed. First (orange) the efficacy of the ligand can be enhanced 
and secondly (brown) the population of the desensitized state is reduced or even completely abolished (Adapted 
from doctoral thesis of I. Zimmermann (18)).   
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8.1.2 Results & Discussion 
The modulation of pLGIC is complex and goes beyond competitive inhibition, open pore 
block and the modulation with divalent ions. The previously described negative effect of 
divalent ions as pore blockers is not their only mode of interaction with pLGICs. They have 
also been described as positive allosteric modulators (PAM) (72). PAMs are able to change 
the population of states in the presence of the ligand and are thus potentially useful tools 
for structural studies. The type which shows the biggest potential for structural studies are 
the type II PAMs, since they are able to reduce or completely abolish the presence of the 
desensitized state (72). This would lead to a decreased conformational diversity in the 
presence of the ligand and a stabilization of the instable open state. It was previously shown 
that the use of a PAM played a critical part in the structure determination of the first 
eukaryotic pLGIC GluCl. There, the known PAM Ivermectin, which binds in the pore 
region, was used to stabilize the open state of the protein (6). 
In an attempt to stabilize the homologue ELIC in a conductive conformation, I have 
investigated whether positive allosteric modulators for this protein exist and they benefit 
my structural studies.  
In an initial approach, I have investigated whether Ivermectin would exert an additional 
activating effect in either of the two homologues ELIC or GLIC. However, the application, 
together with the agonist only had a slightly inhibitory effect. Even the introduction of 
mutants in ELIC and GLIC to closer resemble the binding site of GluCl did not show the 
desired outcome (data not shown). As Ivermectin did not show the expected effect different 
known PAMs of the nAChR were tested (Figure 63) 
 
 
Figure 63: Structures of PAMs activating the α7 nAChR. The molecules are grouped according to their mechanism 
of action.Type I PAMs increase the amplitude but do not strongly alter the kinetics of α7 nAChR -mediated 
agonist-evoked responses. Type II PAMs slow or reverse α7 nAChR desensitization. (72). 
Initial 2EVC experiments in oocytes showed that several of the investigated molecules may 
act as PAMs (Figure 64). By this assay the type I PAMs CCMI, NS1738 and Ly2087101 
and the typ II PAM TQS were found as potential candidates (Figure 64).  
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Figure 64: 2EVC experiments investigating the effect of known enhancers of the α7 nAChR on ELIC at a holding 
potential of -60mV. In addition to the application of cysteamine at its EC50 (350uM) different potential enhancers 
were applied. The concentration for each enhancer was chosen based on their maximal solubility (Tocris AG). All 
potentiators were easily washed out after application. Some compounds show strong activating effects. 
These potentiators showed increased currents upon co-application with the agonist 
cysteamine at its half maximum activating concentration. The most promising candidate 
was Ly2087101. When applied together with the ligand at a concentration of 20 µM, 
currents higher than the Imax for cysteamin activation were observed (Figure 65). 
 
 
Figure 65: 2EVC experiment of X. laevis oocytes expressing ELIC with the PAM Ly2087101 (20 µM) co-applied 
at the EC25 of the agonist cysteamine at a holding potential at -60mV. The currents reached by the addition of 
Ly2087101 are more than 4 times higher than observed by the observed EC25 response, indicating that the channel 
may be even more active than with saturating cysteamine concentrations. This is a common feature for type II 
PAMs, since they reduce desensitization. 
 This indicated that Ly2087101 could act as type II PAM in ELIC, although it is known as 
a type I modulator in the α7 nAChR Receptor. The differences in the mode of modulation 
could be explained by differences in the interaction with ELIC compared to the α7 nAChR. 
I used this compound as additive in crystallization experiments, but despite the fact that 
crystals allowed data collection at 3.2-3.4 Å, the observed conformation was very similar 
to WT. 
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Since the use of PAM did not allow the stabilization of an open state in the crystals, I tried 
to understand which other factors are preventing the homologue ELIC to not undergo the 
desired conformational changes. Thus far all purification and crystallization experiments 
of ELIC were performed in Tris buffer. It was therefore surprising to see that Tris itself can 
modulate the activation of the channel. Electrophysiological experiments showed that the 
addition of 20 mM Tris to cysteamine applied at its EC50 lead to a further increase of the 
currents by about 10% (Figure 66). 
 
 
Figure 66: 2EVC experiment at a holding potential of -60mV. The application of Tris Buffer together with 
cysteamine at its EC50 enhances t the currents by around 10%. 
 
 In a number of initial ITC experiments, Tris buffer (pH7.5) was used. Only later on to 
directly compare binding affinity of the agonist and the antagonist of the 2EVC experiments 
to the ITC experiments the buffer was exchanged to Hepes. When comparing the results in 
Hepes and Tris, an interesting difference in the binding affinity was found. The binding 
affinity of the agonist propylamine in the presence of Tris was more than 1.5 times higher 
than that in Hepes, whereas the binding affinity of acetylcholine was about 2 times lower 
(Table 2 and Figure 67). 
 
 
Table 2: ITC binding affinity. Shown is the comparison of the binding of ELIC WT to the agonist propylamine 
and the antagonist acetylcholine in different buffers (left 25 mM Hepes, right in 25 mM Tris).  
 Buffer:  Buffer:
25 mM Hepes @ pH7 25 mM Tris @ pH7
 150mM NaCl  150mM NaCl
UDM (2xCMC) UDM (2xCMC)
Affinity Affinity
Propylamine 8 mM 5 mM
Acetylcholine 2.5 mM 5 mM
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Figure 67: ITC experiment of ELIC WT at different buffer conditions. (a) Tris: ELIC WT against the agonist 
propylamine (left) and the antagonist acetylcholine (right). (b) Hepes: ELIC WT against the agonist propylamine 
(left) and the antagonist acetylcholine (right). 
Since antagonist binding, unlike the agonist binding, is not cooperative any agonist or 
allosteric/orthosteric modulator would show a similar phenotype. Despite the fact that no 
further experiments were performed to show in which way Tris interacts with the channel, 
its structural similarity to the known partial agonist ethanolamine (Figure 68) is striking.  
 
 
Figure 68: Tris (left) and the partial agonist ethanolamine (right). The structural similarity is apparent thus 
indicating a potential mode of action of Tris as partial agonist. 
The results of my experiments suggest that binding in detergent solution is cooperative for 
the agonist propylamine and non-cooperative for the antagonist acetylcholine which is in 
agreement with previous findings by electrophysiology (18, 67, 69). 
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